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ABSTRACT
Cytoplasmic dynein 1 (dynein) is a microtubule motor that plays a role in mitosis,
cell migration, and minus-end directed microtubule-based transport. The
lissencephaly protein, Lis1, and its binding partner, Ndel1, are critical regulators
of cytoplasmic dynein (Niethammer et al., 2000). In humans, haploinsufficiency of
Lis1 leads to lissencephaly, a devastating developmental neurological disorder
characterized by severe brain malformation, leading to cognitive and motor
defects, and progressively worsening seizures (Dobyns et al., 1993). While Lis1
is known to play a role in regulating dynein-dependent functions such as
neuronal migration and mitotic spindle orientation during development, the
protein is still highly expressed in the adult mouse nervous system, suggesting
an important postdevelopmental role in neurons. Indeed, it has been established
that Lis1 and Ndel1 regulate dynein-dependent axonal transport in mature
neurons (Niethammer et al., 2000; Smith et al., 2000; Pandey and Smith, 2011;
Klinman and Holzbaur, 2015). To further elucidate the importance of Lis1 in the
adult nervous system, we generated a tamoxifen-inducible Lis1 knockout (KO)
mouse to remove the gene post-developmentally. Using an actin promoter to
drive expression of a tamoxifen-inducible cre recombinase, homozygous Lis1 KO
caused the rapid onset of neurological symptoms, such as hind limb clasping and
spinal kyphosis. Administration of tamoxifen resulted in dose-dependent onset of
a severe phenotype, which correlated with the extent of recombination observed
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in the midbrain/hindbrain. Chromatolysis, a sign of axonal dysfunction, was
observed in neurons of brainstem cardiorespiratory nuclei of Lis1 KO animals.
Additionally, transport defects, axonal swellings, and altered neurofilament
distribution were observed in cultured DRG neurons from Lis1 KO mice.
Restricting Lis1 KO to cardiomyocytes resulted in no observed symptoms,
indicating loss of Lis1 in the heart is not the cause of the Lis1 KO phenotype.
Thus my work suggests that Lis1 plays a vital role in autonomic neurons and
disrupted axonal transport is the primary cause of the Lis1 KO phenotype.
Dynein has also been shown to interact with adenomatous polyposis coli
(APC). This interaction is regulated by insulin signaling, specifically through
phosphorylation by glycogen synthase kinase 3 (GSK3) (Gao et al., 2015; Gao et
al., 2017). In wild-type (WT) cells, inhibition of GSK3 causes release of dynein
from APC, leading to accumulation of dynein at the centrosome. In cells with the
multiple intestinal neoplasia (MIN) mutation of the APC gene, GSK3 is unable to
regulate the dynein-APC interaction. Using western blot analysis, I found that the
insulin-signaling pathway remains functional in MIN cells. Since APC binds to
microtubules, which are the tracks for dynein-dependent transport, I looked for
changes in overall microtubule morphology and posttranslational modifications.
No difference was observed in microtubule morphology, but there was less
detyrosinated tubulin in MIN cells. However, this is unlikely to cause the
observed phenotype, as dynein motility is decreased on detyrosinated
microtubules (McKenney et al., 2016). Finally, using coimmunoprecipitation, I
found that dynein interacts with the C-terminus of APC, which is absent in MIN

vii

cells, and not the N-terminus. My work indicates that the absence of the Cterminus of APC, and not alterations of the microtubule cytoskeleton or insulinsignaling pathway, is responsible for the inability of GSK3 to regulate dynein in
MIN cells.
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CHAPTER 1
GENERAL INTRODUCTION
1.1 CYTOPLASMIC DYNEIN
Cytoplasmic dynein 1 (dynein) is a highly conserved minus-end directed
microtubule motor that plays a role in a variety of cellular processes. The multisubunit holoenzyme is comprised of heavy chains (DHC), which contain the
motor and microtubule-binding domains and intermediate chains (DIC), light
intermediate chains (DLIC), and light chains (Tctex1, roadblock, and LC8), which
serve to regulate dynein-cargo interactions (Vale, 2003). This assortment of
subunits, along with other interacting proteins, allows the motor to carry out
diverse cellular processes.
Early work in budding yeast and filamentous fungi implicates dynein in
nuclear migration and mitotic spindle orientation (Eshel et al., 1993; Li et al.,
1993; Plamann et al., 1994; Xiang et al., 1994). Dynein is also critical for mitotic
spindle formation and orientation in mammalian cells (Vaisberg et al., 1993;
O'Connell and Wang, 2000). Dynein also facilitates nuclear envelope breakdown
and localizes to kinetochores during mitosis, where it plays a role in microtubule
capture, chromosome segregation, and progression through the spindle
assembly checkpoint (Pfarr et al., 1990; Steuer et al., 1990; Sharp et al., 2000;
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Howell et al., 2001; Wojcik et al., 2001; Salina et al., 2002; Bader and Vaughan,
2010).
During neurodevelopment, dynein is also important for migration of
neurons and progenitors. Dynein and another microtubule motor, kinesin 3,
mediate interkinetic nuclear migration (INM) of radial glial progenitor cells in the
developing mammalian cortex (Tsai et al., 2007; Tsai et al., 2010; Hu et al.,
2013). Newly formed neurons in the intermediate zone have a multipolar
morphology, but soon transition to a bipolar morphology by extending one neurite
toward the ventricle and another toward the cortical plate. This process is
impeded by knockdown or mutation of dynein (Tsai et al., 2005).
One of dynein’s most pertinent functions for this project is to mediate
microtubule minus-end directed intracellular transport. In the axons of neurons,
microtubules have a uniform “plus-end out” polarity, which means dynein is
responsible for transport of cargoes from the axon terminal back toward the cell
body – a process known as retrograde axonal transport (Baas et al., 1988; Vallee
et al., 1989). The cargoes transported by dynein (and other motors) vary widely
and include ribonucleoproteins (RNPs), membrane-bound vesicles, mitochondria,
and cytoskeletal components.
Since dynein has such a diverse array of cellular functions, its activity
must be tightly regulated. This is done primarily via a combination of proteinprotein interactions, such as with Lis1, Ndel1, or APC, and posttranslational
modifications, specifically phosphorylation of dynein and its regulators by protein
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kinases, such as GSK3 and CDK5 (Allan, 2011; Gibbs et al., 2015). These
regulatory mechanisms will be discussed in the following sections.

1.2 THE ROLE OF LIS1 AND NDEL1 OUTSIDE OF AXONAL TRANSPORT
In humans, haploinsufficiency of the Lis1 gene causes lissencephaly, a
neurodevelopmental disorder characterized by a smooth cerebral cortex,
cognitive and motor deficits, and progressively worsening seizures. Lis1 binds
directly to DHC and regulates many dynein-dependent processes both during
and after development (Sasaki et al., 2000; Smith et al., 2000; Tai et al., 2002).
In fact, decreased Lis1 expression in lissencephaly patients impairs dyneindependent processes in mitosis and migration of neural progenitors, which has
been implicated as the major mechanism underlying the disease (Sasaki et al.,
2000). Depletion of Lis1 alters mitotic spindle assembly and orientation, impeding
proliferation of neural stem cells, leading to depletion of the stem cell population
(Tsai et al., 2005; Wynshaw-Boris, 2007). Aberrant migration is another
consequence of decreased Lis1 expression, which results in ectopic neuronal
positioning, which could contribute to the epileptic seizures seen in lissencephaly
patients (Hirotsune et al., 1998; Tsai et al., 2005; Wynshaw-Boris et al., 2010).
Ndel1, a binding partner of Lis1, operates in a similar capacity during
development through its interaction with DHC via its C-terminal domain, as well
as DIC and Lis1 via independent binding sites on its N-terminal coiled-coil
domain (Sasaki et al., 2000; Tai et al., 2002; Wang and Zheng, 2011; Zylkiewicz
et al., 2011). This interaction with dynein is mediated by phosphorylation of Ndel1
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by cyclin-dependent kinase 5 (CDK5) (Niethammer et al., 2000; Sasaki et al.,
2000). In fact, hypomorphic Ndel1 mutant mice (expressing ~20% of WT levels)
displayed neuronal migration defects and blastocysts of Ndel1 null mice had cell
proliferation defects causing embryonic lethality, similar to Lis1 mutant mice
(Hirotsune et al., 1998; Cahana et al., 2003; Sasaki et al., 2005). Lis1 and Ndel1
are crucial for these processes because they increase dynein force production,
enabling transport of large loads, such as nuclei and chromosomes (McKenney
et al., 2010).

1.3 AXONAL TRANSPORT
As mentioned previously, dynein is the primary mediator of microtubule
minus-end directed transport. Kinesins are a family of primarily plus-end directed
microtubule motors (Vale et al., 1985; Vale, 2003). Since microtubules in axons
have a uniform “plus-end out” orientation, dynein is responsible for transport of
cargoes from the axon terminal or growth cone back toward the cell body
(retrograde transport), while kinesins predominantly mediate transport of cargoes
from the soma toward the end of the axon (anterograde transport) (Vale et al.,
1985; Baas et al., 1988; Vallee et al., 1989; Vale, 2003).
These motors are capable of transporting a wide variety of cargoes to
carry out the diverse processes required to support the axon. Cytoskeletal
components, such as neurofilaments and vimentin, are transported along axons
to support their structure and growth (Lee and Cleveland, 1996; Shea and
Flanagan, 2001; Shim et al., 2008). mRNAs are transported in axons as
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ribonucleoproteins (RNPs) where they can be locally translated in response to
certain stimuli, such as neurotrophin signaling or axon injury (Ben-Yaakov et al.,
2012; Gomes et al., 2014; Villarin et al., 2016). Mitochondrial transport is an
essential process for sustain adequate energy levels for the axon, which may
extend up to one meter in humans. Maintenance of mitochondria along the axon
requires not only the transport of healthy mitochondria to regions of high energy
demand, but also removal of damaged mitochondria through a process called
mitophagy (Misgeld and Schwarz, 2017). Other membrane-bound organelles,
such as endosomes, lysosomes, and autophagosomes are also transported
within axons to recycle or degrade cellular components.
Due to the presence of three distinct, highly specialized cellular
compartments (dendrites, cell body, and axons), motors must be spatially
regulated to ensure transport of cargoes to the proper domain. One distinct
region involved in sorting of cargoes to the correct compartment is the axon initial
segment (AIS). Most organelles likely have both microtubule motors, as well as
the actin-based motor, myosin, associated with them at any time. To facilitate
directional movement of these cargoes, there must be a mechanism (or
mechanisms) to coordinate the numerous motors attached. The uniform
microtubule directionality in the axon allows sorting of axonal and
somatodendritic cargoes through motor regulation. Axonal cargoes carried by
plus-end directed kinesin motors to proceed through the AIS into the axon, while
somatodendritic cargoes are turned away through mechanisms which engage
the minus-end directed dynein motor. One such mechanism involves cyclin-
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dependent kinase 5 (CDK5)-dependent phosphorylation of Ndel1, which is stably
bound to the AIS (Kuijpers et al., 2016; Klinman et al., 2017). This increases
Ndel1 binding to dynein and recruits Lis1 to this complex to activate transport of
these cargoes out of the AIS toward the cell body (Kuijpers et al., 2016)
Another possible mechanism of regulating directionality of cargoes
involves a molecular “tug of war” between opposing motors, where activity of one
type of motor influences the activity of another (Levi et al., 2006; Ally et al., 2009;
Hendricks et al., 2010). An alternative mechanism involves the scaffold protein,
JNK-interacting protein 1 (JIP1), and the dynein regulator, dynactin (Fu and
Holzbaur, 2013). JIP1 binding to kinesin heavy chain (KHC) relieves
autoinhibition of the motor. JIP1 also interacts with the dynactin subunit,
p150Glued, which sequesters JIP1 from binding and activating KHC (Fu and
Holzbaur, 2013). Phosphorylation of JIP1 by JNK acts as a switch to promote its
interaction with KHC, stimulating anterograde transport of amyloid precursor
protein-containing vesicles in axons (Fu and Holzbaur, 2013).
Lis1 and Ndel1 regulate dynein activity in retrograde axonal transport. The
mechanisms behind this are still under some scrutiny, but it is apparent that Lis1
and Ndel1 are critical for proper transport of various cargoes. Previous research
from our lab showed that CDK5 acts as a regulatory switch by phosphorylating
Ndel1 and increasing its interaction with dynein, thereby increasing retrograde
transport of Lysotracker labeled organelles (Pandey and Smith, 2011).
Conversely, phosphorylation of dynein by glycogen synthase kinase 3 (GSK3)
impairs Ndel1 binding, thus decreasing minus-end directed transport (Gao et al.,
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2015). Expression of a dominant-negative form of CDK5 or an Ndel1 mutant
which cannot be phosphorylated by the kinase dramatically reduced transport.
Additionally, knockdown of Lis1 or expression of Lis1 mutants that could not bind
dynein or Ndel1 disrupted retrograde transport (Pandey and Smith, 2011).
Others, however, have observed disruption of dynein-dependent transport of
various organelles when CDK5 activity is increased by overexpression of the
CDK5 activator, p25, which would increase Ndel1 binding to dynein (Klinman and
Holzbaur, 2015). Likewise, there have been contradictory results regarding the
role of Lis1 in the transport of mitochondria. Knockdown of Lis1 in ageing
Drosophila wing neurons augmented mitochondrial transport, while knockdown of
Lis1 or Ndel1 disrupted mitochondrial transport in cultured rat hippocampal
neurons (Shao et al., 2013; Vagnoni et al., 2016).
One explanation for the different effects observed is that regulation of
dynein by Lis1 and Ndel1 is cargo-specific. For example, Lis1 and Ndel1 appear
to play a crucial role in transport of large vesicles in axons, perhaps due to their
ability to increase dynein force production (McKenney et al., 2011; Pandey and
Smith, 2011). Another argument is that the type of regulation is dependent on the
number of Lis1 molecules bound to a dynein motor. A single Lis1 protein binding
to dynein appears to induce tighter binding to microtubules, perhaps conferring
its ability to transport high-load cargoes, while binding of two Lis1 molecules
produces weaker microtubule binding, allowing faster dynein-dependent
transport (DeSantis et al., 2017). Additionally, Lis1’s effects on dynein motility
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may depend on whether another regulatory protein complex, dynactin, is bound
to the motor (Baumbach et al., 2017; Gutierrez et al., 2017).
Dynactin can also stimulate dynein-dependent processes, including
nucleokinesis and organelle transport, directly via its interaction with DIC
(Schroer, 2004). Additionally, dynactin can facilitate dynein’s interaction with
cargoes via adaptor proteins, such as Bicaudal D homologue 2 (BICD2), BICD
related-1 (BICDR1), and HOOK3 (Urnavicius et al., 2018). Interaction of dynactin
with BICDR1 and HOOK3 can recruit two dynein motors to a single complex to
increase force production and velocity (Urnavicius et al., 2018).
While all of the regulatory elements of axonal transport are not currently
known, it is clear that precise control of motor activity and localization are critical
to maintaining the integrity of the nervous system.

1.4 LINK BETWEEN NEURODEGENERATIVE DISEASE AND AXONAL
TRANSPORT
Due to the fundamental importance of intracellular transport, disruption of
this process can have dire consequences, particularly in neurons, whose axons
can extend over distances of up to 1m in humans. In fact, many
neurodegenerative and later-onset neurological diseases have been linked to
defective axonal transport.
For example, impaired retrograde transport of NGF and BDNF have been
linked to Alzheimer’s and Huntington’s diseases, respectively. Endosomal
trafficking and mitochondrial transport are commonly disrupted processes in a
variety of degenerative diseases, such as Parkinson’s disease, upper motor
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neuron diseases, Charcot-Marie-Tooth (CMT), and amyotrophic lateral sclerosis
(ALS) (Hinckelmann et al., 2013; Millecamps and Julien, 2013). Interestingly,
many of these defects are seen in patients with mutations in genes which are not
directly related to axonal transport or microtubule motors. For this reason, it is not
currently known whether disrupted transport is causative in the progression of the
diseases, or merely a symptom due to defects in other processes (Hinckelmann
et al., 2013; Millecamps and Julien, 2013).
Mutations in the dynein motor itself, as well as direct regulators of dyneindependent transport, have also been linked to several later-onset neurological
disorders. These mutations can affect various aspects of transport, including
motor dimerization, processivity, and cargo binding.
Mutations in the dynein heavy chain gene (DYNC1H1) that cause spinal
muscular atrophy with lower extremity predominance (SMALED) have been
shown to disrupt long-distance transport, without affecting cargo binding (Harms
et al., 2012; Hoang et al., 2017). Meanwhile, DYNC1H1 mutations found in
patients with CMT type 2O (CMT2O) are located in the stem domain of the
protein and impair homodimerization (Weedon et al., 2011). Two mouse models
of ALS – Legs at odd angles (Loa) and Cramping 1 (Cra1) – also have
DYNC1H1 mutations that are thought to prevent homodimerization (Hafezparast
et al., 2003). The Loa mutation also affects dynein intermediate chain binding
and transport speeds (Hafezparast et al., 2003). Additionally, mutations in the
dynein regulator, dynactin, cause Perry syndrome, a late-onset neurological
disorder whose symptoms include parkinsonism, weight loss, depression, and
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hypoventilation often leading to insufficient respiration and death, or lower motor
neuron disease (Farrer et al., 2009; Moore et al., 2009). These mutations are in
the CAP-Gly domain of the p150glued subunit of dynactin, which facilitates
microtubule binding and affects dynein function (Farrer et al., 2009; Moore et al.,
2009).
Interestingly, the mutations found in these diseases do not completely
ablate the motor activity, but have a more subtle effect on its function. This could
explain why their effects are seen later in life – complete disruption of motor
activity would result in a devastating phenotype, but relatively minor alterations in
function may lead to accumulation of damaged mitochondria, proteins, or other
problematic cellular components over time.

1.5 THE ROLE OF APC IN NEURONS
Adenomatous polyposis coli (APC) is a tumor suppressor gene expressed
in a wide variety of cell types. Mutations in APC are known to cause colorectal
cancer in humans. It has also been shown to play an important role in the
nervous system. APC is involved in Wnt signaling as part of the β-catenin
destruction complex. It is also a microtubule plus-end binding protein, which
enables it to regulate microtubule dynamics. These functions give rise to its role
in regulating cell polarity and migration (Barth et al., 2008; Purro et al., 2008;
Eom et al., 2014). These are particularly important processes in neurons, as they
contain multiple compartments with distinct polarity and must migrate long
distances in the developing brain.
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APC also plays a role in synapse formation and axon growth. APC is
involved in synapse formation and maturation by mediating PSD-95 and AMPA
receptor clustering at the post-synapse (Shimomura et al., 2007). Additionally,
deletion of APC impairs learning and memory and produces an autism-like
phenotype in mice (Mohn et al., 2014). Deletion of APC also disrupts cytoskeletal
organization in the axon and induces aberrant branching of cortical axons (Chen
et al., 2011). It was recently discovered that APC can act as an RNA-binding
protein and spatially regulate translation of mRNAs, including tubulin isoforms, in
growth cones of extending axons (Preitner et al., 2014). This additional function
may contribute to its role in axon growth.
In addition to interacting with microtubules directly, APC has been shown
to interact with microtubule motors. The localization of APC at the periphery of
fibroblasts and in growth cones of neurons is regulated by kinesin motors (Ruane
et al., 2016). Our lab also found that APC directly interacts with and regulates the
motility of cytoplasmic dynein and mutations in APC abrogate this regulatory
mechanism (Gao et al., 2017). I will discuss my contributions to these studies in
Chapter 4.

1.6 GOALS OF THE PROJECT
The overarching goal of the project is to determine how dynein-dependent
transport is regulated, with an emphasis on axonal transport. Since axonal
transport is disrupted in a variety of neurodegenerative diseases, understanding
the mechanisms that influence this critical cellular process could provide new
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avenues of research and targets for therapeutics for these diseases. Our
hypothesis for these projects is that disruption of dynein-dependent axonal
transport will produce signs of axon degeneration, which will impair neural
function. By studying different pathways, using several techniques (e.g., genetic
approaches, pharmacological manipulations, etc.), we hope to produce a more
comprehensive model for how dynein-dependent transport is regulated and how
dysregulation can lead to axonal pathology.
Additionally, one of the future directions for the lab is to identify the roles
of these dynein regulatory pathways on axon regeneration following nerve injury.
Chapter 2 discusses the role of spatial signaling after axon injury and during
regeneration. While this chapter provides insight into this area of research, there
are still many unanswered questions with regard to the role of dynein and its
regulators during axon growth and regeneration.
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CHAPTER 2
NEURONAL TRANSPORT AND SPATIAL SIGNALING
MECHANISMS IN NEURAL REPAIR1
2.1 INTRODUCTION
Neurons form the circuits that control and coordinate all animal behavior.
These circuits are vital for normal function of the brain, spinal cord, and
peripheral nerves. Intercellular communication generated by transfer of electrical
activity be-tween neurons and from neurons to target tissues is needed for every
movement, sensation, and thought produced. A typical neuron is composed of
three parts: a cell body, several dendrites, and an axon. The dendrites traverse
short distances (≤ 2 mm) and bring activity to the cell body, while the axons are
much longer and transmit activity away from the cell body. A neuron uses
membrane depolarization to rapidly convey the information that is encoded by
neural activity, from ‘post-synaptic’ sites in dendrites to the ‘presynaptic’ sites at
the ‘termini’ of axons (i.e., intracellular communication). Arrival of such an ‘action
potential’ at the axon terminus triggers release of neurotransmitters to propagate
information across neural circuits or directly to the neuron’s target (i.e., intercellular communication). The human neural circuits that connect motor cortex to

1

Kalinski AL*, Hines TJ*, Smith DS, and Twiss JL. Neuronal transport and spatial signaling mechanisms in
neural repair. Encylopedia of Cell Biology, Elsevier Press, Eds. Bradshaw RA and Stahl P. Reprinted here
with permission from the publisher. *indicates equal contributions
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spinal cord to muscle cover a distance approaching 2 m in some individuals. It is
the axons of the motor cortex neuron and the spinal motor neuron that cover
these long distances in the spinal cord and peripheral nerves, respectively.
Disruption of axons through injury or disease blocks normal transmission of this
neural activity and these long axonal processes are particularly vulnerable to
damage.
While propagation of action potentials across these distances occurs on a
millisecond time frame, neurons also use slower forms of intracellular
communication by conveying organelles, protein complexes, and RNA–protein
complexes anterogradely and retrogradely in axons and dendrites. Axonal
transport has been particularly well-studied, and has historic-ally been separated
into fast and slow components based on the speed of labeled proteins moving
within axons. The fast component travels around 100 mm day-1, while the slow
component travels around 1 mm day-1 (Shah and Cleveland, 2002). The cargos
that move in the fast component are important for the growing tips of developing
axons (‘growth cones’) and for the proper function of mature synapses. These
include organelles, membranes, proteins, and RNAs. Fast axonal transport also
conveys signals to the cell body of the neuron that can regulate gene expression.
The slow component of axonal transport ferries cytoskeletal polymers and other
soluble proteins for maintenance of axon integrity (Shah and Cleveland, 2002).
Movement of organelles and complexes within axons and dendrites is essential
for neural function and plays key roles in neural repair.
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‘Molecular motors’ or ‘motor proteins’ play the role of pack animals and
messenger pigeons to move cargos to and from the neuron’s cell body along
axons and dendrites. There are several types of motors but all share certain
attributes, being multisubunit protein complexes that harness the energy of ATP
hydrolysis to move along ‘cytoskeleton’ tracks in axons and dendrites. The rates
at which motors ferry cargo depends on a number of criteria, but in vitro speeds
of individual mammalian motors and also membrane bound vesicles in axons
have been clocked at up to 4 mm s-1. This speed is probably not maintained
consistently, as transport cargos are frequently observed to pause and even
reverse directions within axons and dendrites. Nonetheless, the movement of
cellular components over very long distances in relatively short amounts of time
is a rather herculean task that requires a significant expenditure of energy.
Regulation of motor protein motility, cargo composition, and the organization of
the cytoskeleton tracks within neurons can dramatically influence neuronal
function, particularly during the repair of neural connectivity after injury. Motordependent transport mechanisms are also prime targets for dysregulation in
disease processes that affect the nervous system.
This chapter will cover the contributions of this subcellular trafficking to
neural repair, focusing on the axon. During development, axon growth is
characterized by a rapid elongation phase until targets are reached. At this point
an alternate mode of arborizing growth allows axons to contact target cells and
initiate synaptogenesis. This short-distance sprouting of axons may also underlie
a presynaptic contribution to synaptic plasticity. It should be noted that
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development and regeneration of axonal processes share many common
mediators, so much of this chapter will also be relevant to events in
developmental growth. Although we focus on the repair of axons because of their
fundamental importance in long-range communication in the nervous system,
many of the mechanisms outlined here are also relevant for repair of dendritic
processes.

2.2 CONSTITUENTS FOR INTRACELLULAR COMMUNICATION AND
TRAFFICKING IN NEURONS
2.2.1 THE NEURONAL CYTOSKELETON PROVIDES STRUCTURE, HIGHWAYS
FOR COMMUNICATION, AND GROWTH FUNCTIONS

The three components of the neuronal cytoskeleton, micro-filaments,
intermediate filaments, and microtubules, provide structural integrity for mature
axons and dendrites. Their continued maintenance throughout the life of the
animal supports normal axonal and dendritic function. During developmental and
regenerative events the cytoskeleton itself is highly dynamic; polymerization and
depolymerization of microtubules and microfilaments in the distal ends of axons
(and dendrites) contributes to both growth and pathfinding for axons and
dendrites (Lowery and Van Vactor, 2009). Posttranslational modifications to the
cytoskeleton and associated proteins can contribute to neuronal cytoskeletal
dynamics – for example, cyclin-dependent kinase 5 (CDK5) impacts all three
components of the neuronal cytoskeleton (Smith, 2003). Motor proteins can
contribute to cytoskeletal dynamics by moving short segments of cytoskeletal
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polymers or oligomers as cargo (Shah and Cleveland, 2002). This is particularly
relevant during axon growth and arborization, but even after synapses are
formed, transport of cytoskeletal components is likely to be important for
maintenance of axons. The bulk of this movement appears to occur much more
slowly than the speeds typically associated with fast axonal transport. However,
this slow movement (and perhaps all of the slow component of axon transport) is
thought to be driven by ‘fast’ motors that move the cargo intermittently (Li et al.,
2012).
Microfilaments
Microfilaments are composed of two strands of actin monomers twisted
into helical filaments that have intrinsic polarity. All cells, including neurons, have
a microfilament-rich, mesh-like network on the cytoplasmic side of the plasma
membrane. This ‘cortical actin’ has been proposed to provide a tethering platform
for non-translocating but active motors, allowing them to function in unison to
move small microtubules and attached cellular components within axons and
dendrites (Myers et al., 2006). Polymerization and depolymerization of
microfilaments at the distal end of growing axons and along the axon shaft,
respectively, also play key roles in axon growth and branching. A large number of
proteins have been identified that regulate actin dynamics and the spatial
organization of actin filaments in growth cones (Lowery and Van Vactor, 2009).
Spectrin is another filamentous protein that is concentrated beneath the
plasma membrane, providing a cross-link for the actin cytoskeleton and anchor
for complexes of signaling and structural proteins, including membrane-linked
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protein complexes (Machnicka et al., 2014). Different spectrin isoforms are
concentrated in subdomains of the axon (e.g., axon initial segment, nodes of
Ranvier) that are needed for neural function (Eshed-Eisenbach and Peles, 2013).
Axonal spectrins can be rapidly proteolyzed following axonal injury (Buki et al.,
1999), so reconstruction of these axonal domains and repopulating the axon with
spectrin is a key event in transitioning a regrown axon into a functional axon.
Intermediate filaments
Neuronal intermediate filaments do not provide tracks for motors, but
these proteins have important roles in both axon function and growth. Neuronspecific intermediate filaments provide structural support for growing axons, and
accumulation of one class of filaments, the neurofilaments, dictates the final
caliber of an individual axon (Lee and Cleveland, 1996). The pathophysiology of
some human diseases is accompanied by alterations in neurofilament deposition,
including amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, Parkinson’s
disease, and several neuropathies (Perrot and Eyer, 2009). Posttranslational
modification of the poly-peptides that make up neurofilaments contributes to their
axonal delivery (Szaro and Strong, 2010). The intermittent ‘slow component’ of
microtubule-based transport of neurofilaments may contribute to the precise
deposition of intermediate filaments along the axon (Shea and Lee, 2013). High
levels of neurofilament mRNA and protein levels are typically associated with
more mature neurons. In fact, synthesis of neurofilaments protein falls after
axotomy of peripheral nerves and stays relatively lower during regeneration
(Hoffman and Cleveland, 1988). In some cases phosphorylated neuro-filaments
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accumulate in the soma of regenerating axons, suggesting that transport into
growing axons is reduced (Goldstein et al., 1987).
Another type of intermediate filament protein in neurons, peripherin, is
expressed primarily in peripheral neurons. In contrast to neurofilament
expression, peripherin expression increases during regenerative growth, falling
back to basal levels as axons near their target tissues (Reid et al., 2010). The
axonal inclusions seen in some ALS model mice have been shown to include
peripherin, and overexpression of the ALS-linked protein TDP43 has been shown
to cause a pro-longed increase in peripherin expression after peripheral nerve
injury (Swarup et al., 2012). This implies that the ALS model has an altered
course of neural repair.
Microtubules
Microtubules are the largest of the cytoskeletal polymers, and like
microfilaments, have intrinsic polarity and the potential to be highly dynamic.
Each microtubule is made of 13 parallel protofilaments, which are polymers of αand β-tubulin heterodimers (Prokop, 2013). The organization of the heterodimers
imparts the polarity to microtubules, with the α-subunit nearer to the ‘plus end’
and the β-subunit is nearer to the ‘minus end.’ In axons, microtubules have
uniform polarity with distal plus ends oriented away from the cell body, but
dendrites have mixed microtubule polarity (Baas and Lin, 2011). In motor-based
transport this polarity is important because motor proteins typically prefer to
move in either a plus-end or minus-end direction (Figure 2.1A). Therefore, the
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polarity of microtubules creates a situation in which motors exhibit unidirectional
movement in axons and bidirectional movement in dendrites.
Microtubules shrink and grow due to dimer addition and loss at their plus
ends in a process called dynamic instability (Mitchison and Kirschner, 1984).
Plus ends are the most dynamic, and have a cadre of associated proteins, known
as ‘plus end tracking proteins’ (+TIPs), that regulate their behavior (Schuyler and
Pellman, 2001). Growth and shrinkage occur less frequently at minus ends, in
part because minus-end binding proteins can both protect against microtubule
depolymerization as well as prevent addition of tubulin dimers (Goodwin and
Vale, 2010). With neural injury, the microtubules and neurofilaments are
depolymerized in the axon near the injury site on the proximal side (Figure 2.1B).
The importance of microtubules in axon growth has been known for
decades. The expression of tubulins increases during regeneration, recapitulating
developmental expression levels (Hoffman and Cleveland, 1988). Microtubule
polymerization is a critical and highly regulated process in axon growth; and
drugs that inhibit polymerization can block axon growth in cultured neurons
(Tanaka et al., 1995). Interestingly, stabilization of microtubules with taxol can
augment spinal cord regeneration (Hellal et al., 2011). Microtubule acetylation
has been linked to microtubule dynamics and to regeneration (see below) (Cho
et al., 2013). Microtubule-associated proteins (MAPs) also modify microtubule
structure (e.g., ‘bundling’ of microtubules along the axon shaft), microtubule
stability, and motor protein processivity (Hirokawa, 1994).
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2.2.2 THE GROWTH CONE IS UNIQUELY SUITED FOR ITS JOB
The growing ends of developing and regenerating axons form a
specialized structure called the ‘growth cone’ (Figure 2.1C). The shape and
behavior of the growth cone is dictated by both extrinsic and intrinsic factors
(Gomez and Letourneau, 2014). Examples of extrinsic factors are substrate
molecules in the extracellular milieu or matrix (ECM) present along the growth
trajectory, and molecules secreted locally into the environment by neighboring
cells. Intrinsic factors include cytoskeletal dynamics that are often regulated by
proteins within the growth cone like the Rho, Rac, and CD42 small GTPases, as
well as the spatial distribution of receptors for sensing environmental cues.
Generation of a growth cone after an axon is injured is generally thought to be
essential for regenerative growth. One of the initial events in establishing a
growth cone after injury is the entrance of calcium into the damaged axon – as
outlined in subsequent sections, this triggers a number of changes that not only
allow this important structure to form, but also facilitates signaling to the neuronal
cell body (Bradke et al., 2012).
While growth cones can vary greatly in shape and behavior, a typical
advancing growth cone is composed of three major domains: central (C-),
transition (T-), and peripheral (P-) domains (Gomez and Letourneau, 2014). The
C-domain is made up of stable microtubule bundles that come from the axon
shaft. These microtubules tend to be acetylated in the axon shaft and as
microtubules enter the growth cone, tyrosination becomes the prominent
posttranslational modification on the tubulins (Figure 2.1C). Acetylated tubulin is
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associated with stable polymers, while tyrosinated tubulin is associated with
more dynamic polymers (Janke, 2014). The C-domain typically contains the more
dynamic microtubules that can extend linearly in sync with the advancing edge of
the growth cone. However, microtubules are responsive to environmental cues,
and can shrink back or become curved in order to pause advancement or to
reorient direction of growth (Lowery and Van Vactor, 2009). The P-domain at the
very leading edge of the growth cone is composed of actin-based projections
called lamellipodia and filopodia. Microfilaments in lamellipodia form a dynamic
mesh, with new filaments being added to growing edge and old filaments being
broken down at the back of the mesh near the C-domain. Force-generating
myosin motors (see below) control the contractility of this meshwork (Medeiros et
al., 2006). The filopodia, are finger-like projections outward from lamellipodia that
extend and retract to sample their environment. They contain dynamic bundles of
actin filaments, which are thought to form through the concerted action of
myosin-driven ‘retrograde flow’ of the actin mesh in lamellipodia and the
extension of actin polymers in the filopodia (Medeiros et al., 2006).
The dynamic nature of the cytoskeleton in growth cones is what allows
these structures to respond to environmental cues, and growth cones ultimately
must transition into synaptic endings or other types of functional axon termini.
When the growth cone adheres to a substrate such as laminin, the actin
cytoskeleton becomes anchored to receptors, preventing retrograde movement
of actin, which causes the filopodia of the growth cone to extend or protrude via
distal actin polymerization (Mitchison and Kirschner, 1988). As this happens,
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myosin motors create tension between F-actin filaments and an F-actin arc at the
base of the growth cone closest to the axon shaft. This allows microtubules of the
C-domain to move forward, leading to an engorged growth cone; after this, the Factin arc depolymerizes and the membrane collapses around the stable
microtubule bundles, consolidating this region into an extension of the axon shaft
(Lowery and Van Vactor, 2009). It should be noted that localized synthesis of βactin protein and actin-interacting proteins in growth cones may also contribute to
actin dynamics in the growth cone, as well as along the axon shaft where
collateral branches form (Zhang et al., 1999; Spillane et al., 2013). Motor protein
regulators (e.g., lissencephaly protein (Lis1) and nuclear distribution E-like 1
(Ndel1), see below) are prominent in growth cones of regenerating axons in
culture (Niethammer et al., 2000; Smith et al., 2000), and can play an active role
in promoting growth cone motility.

2.2.3 MOLECULAR MOTORS FERRY CARGO TO AND FROM AXONS AND
PROVIDE FORCE GENERATION FOR AXON GROWTH
Molecular motors transport of a wide range of cargos in axons including
organelles, vesicles, mRNA, and signaling molecules. The mRNAs move as
RNA–protein complexes termed ‘ribonucleoproteins’ (RNPs) (Gomes et al.,
2014). Cargo may be deposited along axons, or trafficked anterogradely to
synapses and growth cones or retrogradely back to the cell body. Transport
along microtubules is carried out by kinesins, which for the most part are plusend directed, and cytoplasmic dynein, which is minus-end directed (Hirokawa et
al., 2010). Cytoplasmic dynein also has the capacity to become tethered to the
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cortical actin cytoskeleton within axons and growth cones. The force generating
heads that project into the axon away from the cortical actin are then able to
‘kick’ short microtubule segments, causing them to move with their plus-ends
leading (Mazel et al., 2014). In addition to microtubule motors, axons contain
myosin motors that ferry cargo on microfilament tracks. While these three
classes of motors share common features, including motor domains that require
ATP, they are also quite distinct with respect to molecular organization as well as
motility regulatory mechanisms.
Kinesin
There are 14 classes of kinesin superfamily proteins organized in part by
where the motor domain is located within the polypeptide (Hirokawa et al., 2009).
‘Conventional’ kinesins in the Kinesin-1 group are heterotetramers. Two ‘heavy
chains’ (kinesin heavy chain, KHC) form a dimer with globular head domains that
interact with microtubules and undergo force-producing conformational changes
in response to ATP binding and hydrolysis. KHC stalk regions contain the
dimerization domains, while the C-terminal tails interact with ‘light chains’ (kinesin
light chain, KLC) that confer cargo binding (Marx et al., 2006). Though the motor
domains are well conserved, substantial variability in other parts of the
heteromer, including KLCs, can confer cargo selectivity. Kinesins move a variety
of cargo toward axon termini, so they are critical for maintenance of mature
axons and synapses, as well as for delivery of construction materials, receptors,
adhesion proteins, and membranes to growing axons (Figures 2.1(a) and 1(b)).
Different kinesins in this large superfamily are responsible for anterograde
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transport of specific cargo types within axons. Some of the specificity is likely
derived from distinct heavy chains, but cargo-specific transport by the same
heavy chain can be modulated by associated light chains (Hirokawa et al., 2009).
Dynein
Although a few kinesins (e.g., KIFC2) may be capable of minus enddirected transport (Hirokawa et al., 2009), the pre-dominant minus end-directed
motor in axons is cytoplasmic dynein (Figures 2.1A and B). This huge protein
complex contains 12–14 subunits and has 2 identical heavy chains (dynein
heavy chain, DHC) that form a dimer (Vale, 2003). The large ring-shaped motor
domains at one end of DHC are ATPases, and are the force-generating
component of the protein complex. A stalk extending from each DHC motor
domain interacts with microtubules. DHC’s stem interacts with an array of other
‘chains.’ These include two intermediate chains, 2–3 light intermediate chains
and 3 distinct light chains. It is generally believed that the accessory subunits
bind to adaptors that confer cargo specificity and/or control dynein processivity
(Allan, 2011). The cytoplasmic dynein holoenzyme is fairly uniform in subunit
composition. However, multiple genes encode related but distinct isoforms of
each accessory subunit. Moreover, alternative splicing and post-translational
modifications can alter subunit composition to optimize dynein motors for
different tasks (Pfister et al., 1996). Because axonal dynein moves retrogradely
toward the cell body, it is important for molecular communication between axon
endings and the nucleus. In intact axons, dynein carries information related to
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synapses and target tissues, and convey signals that prevent continued axon
elongation after developmental growth has ceased (Smith and Skene, 1997).
Myosin
Myosin is a force-generating ATPase that underlies muscle contraction.
The classic muscle myosin remains tethered in place and brings about muscle
contraction by exerting tugging forces on actin filaments. Some myosins in
neurons also function by exerting forces on the subcortical actin network (Figure
2.1C) – these are particularly prominent in regulation of growth cone dynamics
needed for development and re-generation (Lowery and Van Vactor, 2009).
Other members of the myosin superfamily are processive and can ferry cargo,
using microfilaments as transport tracks. Some myosins (e.g., myosin Va) are
plus-end directed, and others (e.g., myosin VI) are minus-end directed (Kneussel
and Wagner, 2013). Myosin transport is typically thought to occur over shorter
distances than the long-range axonal transport associated with microtubule
motors (i.e., at branch points, in growth cones, in synapses, etc.).
Regulation of motor proteins – Activation, inhibition, and cargo selectivity
Much of what we know about motor regulation has come from in vitro
studies with purified proteins or cultured cells. However, studies in neuronal
cultures suggest that these mechanisms are likely relevant to nerve repair.
Because of their force-generating capacities, their plethora of cargos and the
many cellular processes influenced by motors, a strictly enforced regulatory
network must be in place to coordinate motor behaviors and modulate their
behaviors in response to environmental cues and intrinsic cues. At the most
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basic level, ATP must be in good supply for all motors to function properly.
Perhaps intuitively, mitochondrial ATP was shown to be the source of ATP for
fast axon transport of mitochondria (Zala et al., 2013). However, the source of
ATP for transport of some vesicular cargos appears to be from glycolytic
machinery directly associated with the vesicle (Zala et al., 2013). Thus, the cargo
itself can impact activity of the motor protein carrying it, and there is a growing
understanding that complexes of motor proteins, scaffolds, and regulatory
proteins can modulate motor processivity and force generation. The selection of
a motor’s cargo is in part regulated by cargo adaptors, proteins that bind to both
the motors and to a specific type of cargo (Fu and Holzbaur, 2013). An
interesting new development is that mammalian cytoplasmic dynein is incapable
of moving along microtubules in vitro in the absence of either cargo or cargo
adaptor proteins (McKenney et al., 2014; Schlager et al., 2014). It remains to be
determined if this is also the case within the confines of the axon shaft.
Knowledge of motor protein regulation has been advanced by studies of
neurological disorders. For example, mutant forms of huntingtin (HTT) protein
that cause Huntington's disease form aggregates in axons and dendrites that can
block transport by motors (Lee et al., 2004). Wild-type HTT can bind directly to
dynein intermediate chain (DIC) subunits (Caviston et al., 2007), while an HTT
binding partner HTT-associated protein 1 (HAP1) interacts with KLC (McGuire et
al., 2006). Moreover, HTT is involved in linking the glycolytic machinery to cargo
vesicles to provide a ready source of ATP for fast axonal transport (Zala et al.,
2013). While pathogenic HTT remains capable of interacting with motor
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complexes, it reduces motor association with microtubules through a c-Jun Nterminal kinase 3 (JNK3)-mediated phosphorylation of kinesin-1 (Morfini et al.,
2009).
Most organelles have all three classes of motors associated with them,
usually more than one of each kind of motor. Interactions between motors may
occur via scaffolding systems (Fu and Holzbaur, 2013). There is growing
evidence that motors of one class can affect activity of other classes of motors
(Levi et al., 2006; Ally et al., 2009). While many of these interactions have been
observed, how functions are coordinated to regulate cargo movement in the
same axons has not been extensively studied. The precise trafficking of an
individual cargo likely involves regulation of the stoichiometry of motor
association, a tug of war between opposing motors of all three classes, the
proximity of transport tracks, as well as posttranslational modification of proteins
and cargos (Kardon and Vale, 2009; Fu and Holzbaur, 2013). Each of these
mechanisms is operant in the mature as well as injured and regenerating axon.
One known molecular control mechanism involves the JNK-interacting protein 1
(JIP1) that acts as a scaffold protein that binds to both KHC and the dynein
activator, dynactin (Fu and Holzbaur, 2013). JIP1 binding to KHC relieves an
intramolecular autoinhibition of kinesin motor activity. The dynactin subunit
p150Glued competes with KHC for binding to JIP1 so that KHC is inactive when
JIP1 is bound to p150Glued. Kinesin disinhibition and dynactin binding by JIP1 is
regulated by JNK-dependent phosphorylation, which can lead to directional
changes in movement of amyloid precursor protein-containing vesicles in axons
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(Fu and Holzbaur, 2013). JIP1 is also responsible for directional selectivity of
autophagosomes in axons. Autophagosomes are retrogradely transported by
dynein, and are presumed important for axonal maintenance and growth. Dual
mechanisms appear to prevent activation of kinesin on these organelles (Fu et
al., 2014). JIP associates with autophagosomes through the adaptor,
microtubule-associated protein light chain 3 (LC3), and LC3 prevents JIP binding
to KHC.
Other proteins can bind directly to motors and regulate force generation
and/or processivity in vitro and also impact axon transport in cultured cells. For
example, loss of Lis1 protein reduces retrograde transport of acidic vesicles and
Lis1 overexpression increases speed and run lengths of retrogradely moving
vesicles in axons (Pandey and Smith, 2011). Lis1 seems to function with dynein
to promote microtubule advance during growth cone remodeling and fast axon
growth (Grabham et al., 2007). During embryogenesis, Lis1 contributes to
neuronal migration (Reiner and Sapir, 2013), and it interacts with two paralogous
dynein-binding proteins Ndel1 and Nde1 (Bradshaw et al., 2013). Ndel1/Nde1
also serves as a platform for modulation of motor activity by posttranslational
modification. Ndel1/Nde1 strengthens the Lis1 association with dynein and
increases force production by promoting cooperation between multiple dynein
motors (McKenney et al., 2010). Interestingly, the neuronally enriched kinase
Cdk5, phosphorylates Ndel1/Nde1 (Niethammer et al., 2000). Phosphorylation of
Ndel1 by Cdk5 is important for dynein-dependent organelle transport in growing
axons extended by adult sensory neurons in culture (Pandey and Smith, 2011).
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Recent evidence suggests that Cdk5 is an important regulator of membrane
vesicle dynamics in growth cones (Hsiao et al., 2014; Tojima et al., 2014). Other
kinases that contribute to regulation of axonal transport have also been observed
to impact regeneration. For example, glycogen synthase kinase 3 (GSK-3) exerts
a negative influence on axon transport in squid and fly axons (Morfini et al.,
2002). GSK-3 has shown varying effects on axon regeneration, but recent work
indicates that sustained activation of GSK-3 supports regeneration of axons in
peripheral nerve (Gobrecht et al., 2014). Clearly, the interplay between signals
regulating axon transport and those regulating axon growth is complex, and just
beginning to be understood.
How extracellular stimuli regulate motor proteins is also not well
understood, but some pathways are beginning to emerge. For example,
activation of semaphorin receptors along growing axons stimulates both
anterograde and retrograde movement of axonal vesicles (Li et al., 2004).
Semaphorin stimulation of distal axons shifts α-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid (AMPA) receptor subunit localization to dendrites through
a coordinated retrograde signaling in axons and subsequent anterograde
transport in dendrites (Yamashita et al., 2014). Neurotrophins also impact
transport. These ligands increase endosome binding to dynein through DIC
phosphorylation, thereby stimulating retrograde transport (Mitchell et al., 2012).
Interestingly, neurotrophin receptors (Trks) are endocytosed in axons along with
their ligands and can be retrogradely transported as a ‘signaling endosome’ that
carries downstream effector kinases to the cell body (Schmieg et al., 2014).
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During development, many neuronal populations compete for binding to targetderived neurotrophins and other trophic agents. The neurons that do not secure
an appropriate source of trophic support are eliminated through naturally
occurring cell death. Culture preparations in which the neurons’ cell body and
axons are compartmentalized have shown qualitative differences in the response
to neurotrophic stimulation of distal axons compared to the cell body (Campenot
and MacInnis, 2004). This suggests that the signaling endosome conveys a
signal different from Trk receptors endocytosed along the cell body.
Activation of Trk receptors along the axon has been shown to modulate
transport of RNPs into axons, with accumulation and translation of mRNAs
adjacent to the trophic stimulus along axons (Willis et al., 2007). Target-derived
nerve growth factor (NGF) in sympathetic neurons was recently shown to
coordinate transcriptional responses in the cell body with delivery of mRNA
encoding a survival promoting protein, B-cell lymphoma w (Bclw), to the axons
(Cosker et al., 2013). Given that peripheral nervous system (PNS) injury results
in increased expression of neurotrophins and other trophic factors by Schwann
cells in the severed nerve stump (Funakoshi et al., 1993), it is intriguing to
hypothesize that signaling endosomes moving retrogradely to the cell body would
be used to coordinate anterograde delivery of macromolecules to the
regenerating axons. The cargos that motor proteins deliver into axons obviously
play a role growth and regeneration. The axon needs new cytoskeleton and
membrane components to grow, as the severed segment of the axon distal to
injury site undergoes Wallerian degeneration in mammals (see below). It was
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also recently recognized that protein products of axonally transported mRNAs
support regeneration in the PNS (Donnelly et al., 2013), and there is some
evidence that this may occur after spinal cord injury as well (Willis et al., 2011).

2.3 NEURAL REPAIR MECHANISMS
2.3.1 INJURY CHANGES AXON STRUCTURE AND AXONAL TRANSPORT TO
INITIATE A REGENERATION PROGRAM
With damage and severing of an axon, the segment distal to the site of injury
(i.e., the portion no longer connected to the cell body) is actively degraded
through Wallerian degeneration. In the portion proximal to the site of injury, influx
of Ca2+ from extracellular spaces promotes membrane sealing and locally
activates proteases (Bradke et al., 2012). Proteases degrade axonal proteins
including cytoskeletal elements, and this is necessary for the initiation of axonal
growth (Ziv and Spira, 1997). The increase in axoplasmic Ca2+ also triggers
retrograde signaling through transport mechanisms (Rishal and Fainzilber, 2010).
This shift in retrograde transport ultimately helps to turn on expression of genes
that support growth (regeneration-associated genes (RAGs)) and turn off
expression of genes associated more with mature neuronal functions (Rishal and
Fainzilber, 2010). For example, axotomy in the PNS increases the expression of
growth-associated protein-43 (GAP-43) and Tα1-tubulin, but decreases
expression of neurofilaments. Injury to the mammalian brain or spinal cord, in
contrast to peripheral nerves, often does not activate expression of RAGs, and
this may in part, underlie the reduced growth capacity of mammalian central
nervous system (CNS) neurons after injury (Hoffman, 2010). Many strategies to
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increase axon regeneration after central injuries have focused on altering the
‘intrinsic growth capacity’ of CNS neurons through changing gene expression
programs (Mar et al., 2014). ECM glycoproteins and glial-derived proteins in the
injured brain and spinal cord also actively block axon growth, and over-coming
these ‘roadblocks’ is often a complimentary strategy to support CNS neural repair
(Geoffroy and Zheng, 2014).
Some of the mechanisms that underlie the shift in retrograde axonal
transport are known. Axonal JNK3 is locally activated after injury, with a resulting
increased association of a complex of JNK-interacting proteins 3 (JIP3) and
activated JNK3 with the p150Glued subunit of dynactin, and increased retrograde
transport of activated JNK3 (Cavalli et al., 2005). This leads to activation of c-Jun
in the neuronal cell body that presumably supports expression of genes needed
for regeneration (Ruff et al., 2012). Interestingly, JIP3 binding to KHC can also
increase kinesin motility (Sun et al., 2011). It is not clear whether the JIP1dependent retrograde transport of autophagosomes mentioned above
contributes to neural repair; however, it is intriguing that both JIP1 and JIP3 can
coordinate anterograde and retrograde transport (Fu and Holzbaur, 2014). This
provides a powerful mechanism to coordinate transport to meet physiological
needs of the neuron and potentially to recycle proteins between axons and cell
body.
Calcium influx coordinates the injury response
The influx of Ca2+ into injured axons also triggers translation of locally
stored mRNAs (Perry and Fainzilber, 2014). These mRNAs are transported into
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axons as RNPs and it remains unclear exactly how Ca2+ influx activates
translation locally in axons, but it likely includes a commensurate release of Ca2+
stores from sites in axons (Vuppalanchi et al., 2012). Axonal mRNAs known to
be translated by increased axoplasmic (Ca2+) include Importin β1, Ran specific
binding protein 1 (RanBP1), and vimentin (Gomes et al., 2014). These encode
proteins that contribute to a retrograde injury signal in a complex highly
orchestrated process (Rishal and Fainzilber, 2010). The newly translated
Importin β1 in axons heterodimerizes with Importin α3 (Hanz et al., 2003).
Localized synthesis of RanBP1 facilitates this by releasing α3 from an
anterograde transport complex (Yudin et al., 2008)). Interaction of the Importin
β1/α3 complex with dynein is needed for the transport of proteins containing
nuclear localization signal (NLS) to the nucleus. The cargo of the dynein-Importin
β1/α3 complex includes other proteins that are locally synthesized with injury
(e.g., signal transducer and activator of transcription 3α, Stat3α) as well as
proteins that are locally activated through injury-induced posttranslational
modifications (e.g., extracellular-regulated kinase, Erk 1/2) (Perlson et al., 2005;
Ben-Yaakov et al., 2012). Vimentin has been considered as a glial intermediate
filament protein in the nervous system, but vimentin can be expressed in
neurons, and its mRNA has been shown to localize to axons (Willis et al., 2007).
Curiously, proteolytic cleavage of vimentin in injured axons generates a 'scaffold
peptide' for activated Erk 1/2, a mitogen-activated protein kinase (MAPK), to bind
to Importin β1/α3 dimer. This kinase is transported to the cell body with dynein,
where it activates Elk1 (and possibly other) transcription factors (Perlson et al.,
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2005). It is likely that such a posttranscriptional mechanism is shared with other
physiological responses of axons, since neurodegenerative stimuli, neuronal
survival promoting stimuli, and a neurotropic virus are now recognized to couple
events in the distal axons to cell body responses through translation of axonal
mRNAs (Cox et al., 2008; Cosker et al., 2013; Koyuncu et al., 2013; Baleriola et
al., 2014). These and other studies indicate that axonal injury induces a
localized, integrated response to shift retrograde transport toward cargos that
assist in mounting a regenerative response. The full extent of these cargos has
yet to be determined.
Calcium influx transforms the injured axon to support regenerative growth
Much of what we know about axonal transport and localized growth
mechanisms have been derived from studies in cultured neurons, where events
can be spatially and temporally monitored with high precision. Neurons cultured
from invertebrate organisms have provided a platform for visualizing cytoskeletal
dynamics in growing and injured axons. For example, the initial studies on Ca2+
signaling after axonal injury resulted from work in Aplysia neurons (Ambron and
Walters, 1996). The Ca2+ gradient that forms in these axons after injury occurs in
both the proximal (intact) and distal (severed) segments of the injured axon, but
only the proximal end undergoes regeneration (Ziv and Spira, 1997). The Ca2+
dependent events including membrane sealing and cytoskeletal restructuring
controlled by calcium-activated calpain, syntaxin, synaptotagmin, and
synaptobrevin are critical for neural repair (Bradke et al., 2012). Indeed,
activation of calpain through a Ca2+-dependent mechanism is required for growth
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cone formation (Gitler and Spira, 2002). Proteolysis of cytoskeletal elements in
the cut axon results in a reorganization of microtubule polarity in Aplysia (Sahly
et al., 2006). This may generate a ‘trap’ for capturing both anterogradely and
retrogradely transported vesicles, which are then available to fuse with the
plasma mem-brane for efficient and effective formation of a growth cone (Erez
and Spira, 2008). Work in vertebrate neurons indicates that activation of localized
protein synthesis in the distal cut axon is also needed for growth cone formation
(Verma et al., 2005). Though the proteins synthesized were not identified, TC10
and Exoc3 mRNAs, which encode components needed for plasma membrane
expansion, are locally translated in growing axons (Gracias et al., 2014).
Stimulation of MAPKs and mammalian target of rapamycin (mTOR) converge on
protein synthesis machinery and are needed for growth cone formation (Bradke
et al., 2012). Thus, localized mRNA translation supports the initial transition of an
injured axon into a regenerating axon. Subsequent growth of the axon requires
delivery of necessary building blocks of cytoskeleton and membrane
components, which is accomplished by anterograde transport of proteins,
vesicles, and RNPs.

2.3.2 UNEXPECTED ROLES FOR PROTEINS IN GROWING AXONS
Axonal functions for nuclear proteins
With technical advancements in subcellular imaging, protein/ RNA detection and
analyses, and study of signal transduction mechanisms, previously unrecognized
functions have been ascribed to proteins and protein networks that support
neural repair. For example, epigenetic regulation is now well recognized as a
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means to modulate expression of entire gene families, and there is clear potential
for such chromatin-based modulation to contribute to neural repair (Finelli et al.,
2013). However, recent work from two groups have uncovered intra-axonal
functions for histone deacetylase (HDAC) proteins that are classically viewed as
modifiers of chromatin structure and, hence, transcription. The injury-induced
Ca2+ entry into axons noted above produces a retrograde ‘Ca2+ wave’ that
triggers exit of HDAC5 from the nucleus in a protein kinase C-dependent
pathway. In keeping with classic functions of HDACs, the loss of HDAC5 from the
nucleus supports expression of genes whose encoded proteins have roles in regeneration (e.g., c-Fos, c-Jun, KLF4, KFL5, and Gadd 45a; see Cho et al., 2013
and references within). However, HDAC5 is also anterogradely transported into
the injured axon, where it supports deacetylation of microtubules. This decreases
stability of microtubules in the cut axon that is needed for growth cone formation
just proximal to the injury site. Curiously, this anterograde movement of HDAC5
only occurred after peripheral nerve injury and not after optic nerve injury, a
lesion of CNS axons (Cho et al., 2013), pointing to another distinction between
the central and PNS with axonal injury (Cho et al., 2013). HDAC6 protein has
also been shown to function in axons, but inhibition of HDAC6, rather than
activation, brings growth-promoting effects (Rivieccio et al., 2009). For HDAC6
inhibition, this allows for growth on nonpermissive substrates including myelinassociated glycoprotein and CSPGs that block axonal growth after spinal cord
injury. These observations suggest that HDAC5 and HDAC6 have antagonistic
functions in neural repair. However, HDAC6 may contribute to axon health
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because it facilitates the retrograde transport of protein aggregates for
destruction in autophagosomes (Lee et al., 2010). It will be intriguing in the
coming years to discover the mechanism of action and targets of these
deacetylases in developing, regenerating the mature axons.
New functions for adenomatous polyposis coli protein, a protein associated with
colorectal cancer
Other proteins have shown multifunctionality that impacts axon development and
likely axon regeneration. Adenomatous polyposis coli protein (APC) is a large,
multidomain microtubule-interacting protein initially discovered because
truncating mutations lead to colorectal cancer in humans (Vogelstein and Kinzler,
2004). APC has also been linked to axon growth through promoting microtubule
polymerization (Chen et al., 2011). In addition to its function as a +TIP, APC
interacts with many different proteins including β-catenin and GSK-3β from the
canonical Wnt signaling pathway (Clevers and Nusse, 2012). Initial studies in
fibroblasts raised the possibility that APC’s actions may also extend to interaction with mRNAs (Mili et al., 2008). More recent work has shown that APC
binds directly to more than 250 neuronal mRNAs (Preitner et al., 2014).
Interestingly, nearly half of those mRNAs were known to localize into growing
axons of PNS sensory neurons, including the Importin β1 and β-actin mRNAs
that are mentioned above. Preventing APC binding to a tubulin isoform mRNA
(TUBB2B2) decreased axonal levels of this mRNA and caused growth cones to
shrink, which could significantly hamper the growth cone’s ability to interact with
growth substrates (Preitner et al., 2014). Though it is not clear whether APC is
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needed for transport or translation of these mRNAs (or both), the protein is
perfectly positioned in the growth cone to serve as a scaffold concentrating
mRNAs and translational machinery near the processive tips of micro-tubules.
There is work in developing neurons indicating that localized mRNAs accumulate
along with translation factors and ribosome subunits adjacent to cytoplasmic tails
of axon guidance receptors (Tcherkezian et al., 2010). It will be interesting to see
if APC also contributes to transport or translation of mRNAs in injured axons
where localized protein synthesis is known to contribute to regeneration.
A protein kinase that can regulate both axon regeneration and Wallerian
degeneration
Genetic screens in model organisms, including flies, worms, and mice, identified
the ‘dual leucine zipper kinase’ (DLK) as regulator of both axon regeneration and
degeneration (Tedeschi and Bradke, 2013). DLK has also been called ‘ZPK’ in
mice and ‘Wallenda’ in Drosophila. Loss of DLK delays degeneration of axons
but also attenuates RAG transcription in the cell body (Shin et al., 2012a).
Activation of DLK can lead to downstream activation of both JNK and 38 kDa
mitogen-activated protein kinase (p38MAPK). As emphasized above, JNK
activation is important in neural repair, and downstream c-Jun dependent
transcription activates expression of RAGs in the cell body after axonal injury
(Shin et al., 2012a). However, blocking JNK activation in severed axons distal to
the injury site delays Wallerian degeneration, indicating dual functions for both
DLK and JNK (Ferraris et al., 2013). In addition to JNK’s roles in axonal transport
mediated through JIPs, JNK is known to target microtubule binding proteins that
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regulate dynamic stability of these cytoskeletal elements, which can influence
both axon formation and regeneration (Tedeschi and Bradke, 2013). JNK
phosphorylation triggers degradation of super cervical ganglion clone 10
(SCG10, also called Stathmin-2) in axons (Shin et al., 2012b). SCG10 is a
membrane bound protein that destabilizes microtubules (Riederer et al., 1997).
Degradation of SCG10 in the severed axon is linked to Wallerian degeneration,
but SCG10 is rapidly replenished in the proximal axon segment proximal to the
injury and this is needed for regeneration (Shin et al., 2014). Destabilization of
axonal microtubules through SCG10’s actions near the growth cone contributes
to axon motility. JNK is also known to phosphorylate microtubule-associated
protein 1b (MAP1b) in axons, which conversely increases stability of
microtubules (Chang et al., 2003). Interestingly, the mRNA encoding a protein
kinase that can be an intermediate between DLK and JNK, MKK7, or mitogenactivated protein kinase kinase 7 (MAP2K7), localizes to proximal neurites of
differentiating NIE-115 cells and primary hippocampal neurons (Feltrin et al.,
2012). This may provide a means to compartmentalize the functional outcome of
JNK’s activation in growing axons, by concentrating substrates that differentially
modify microtubule dynamics to different sites along the axon (e.g., growth cone
for destabilization vs. axon shaft for stabilization).
Regulation of microtubule motor proteins can directly support axon regeneration
Interestingly, kinesin and dynein motors have recently been shown to
have unexpected roles in attenuating axon growth. The levels and/or activity of
kinesin and dynein motors may contribute to axonal growth by providing a gauge
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for how much material the axon needs in order to grow (Albus et al., 2013). In
cultures of adult sensory neurons, partial depletion of kinesin and/or dynein
heavy chains with siRNA actually increases axon length over time (Rishal et al.,
2012). Legs at odd angles (Loa) mice that have reduced levels of dynein heavy
chain 1 (Dync1h1) show increased axon length in developing limb buds
indicating that this length sensing mechanism is also relevant for axon growth in
vivo (Rishal et al., 2012). These data suggest that continual anterograde and
retrograde signaling, analogous to a radar signal, contributes to axon growth
rates (Kam et al., 2009). However, the cargos that are needed for this, both those
carried anterograde into the axons and those carried retrograde back to the cell
body, are not clear
Work from the Baas group using depletion of kinesins also suggested that
localized interactions of kinesin and dynein motors could affect axon length (Liu
et al., 2010). They observed that partial depletion of kinesin-5 or kinesin-12 increased axon length in cultured neurons, but attributed this to a shift in the
tractile forces along the distal axon to favor increased growth (Myers and Baas,
2007; Liu et al., 2010). They hypothesized that loss of either kinesin allows
cytoplasmic dynein to pull microtubules in the opposite direction, moving more
microtubules from the axon shaft into the growth cone, resulting in both increases
in axon length and the inability of the growth cone to turn properly without spatial
control over the microtubules in the growth cone (Liu et al., 2010). Regardless of
whether this is a cargo-dependent signaling mechanism or localized force
differentials through altered motor stoichiometry, the end result of decreasing
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motor protein activity results in the counter-intuitive effect of increasing axon
length. It will be of substantial interest to determine how these mechanisms can
be integrated with the injury-dependent and regeneration-associated changes in
axonal trafficking out-lined above that are essential for repair of neural
connectivity.

2.4 PERSPECTIVES
Despite all that has been learned of neural repair mechanisms and the
potential for using trafficking to encourage axons to regrow after injury, even is
the PNS where regeneration is relatively robust, regenerating axons only
progress at 1–2 mm per day. Thus, finding a means to increase growth rates
should bring huge benefits. However, whether increased growth rate can be
accomplished be modulating axon transport dynamics in vivo remains to be
determined. Interesting potential targets for regulating axon growth through
trafficking include the motors themselves, their regulatory partners, kinases,
cargo adaptors, and specific cargos.
In addition to overt axon elongation driven by growth cone advance,
developing neurons must also undergo a different kind of axon growth even after
synapse formation. Small-scale axon growth and remodeling of synaptic
connections occur throughout adult life and underlies learning and memory. But
this does not compare to increased length that nerves and axon tracts
accomplish during growth from a late stage embryo to late adolescent, and is
unlikely to be the mechanism underlying this elongation. There is some evidence
that neurons switch to a stretch-induced interstitial growth as organisms increase
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their rostral-to-caudal dimensions (Suter and Miller, 2011). Cultured sensory
neurons have been ‘stretched’ in an attempt to model this process, and within
limits, stretching results in increased rates of axon growth while maintaining
electro-physiological function (Pfister et al., 2006). The mechanisms underlying
this increased growth are not clear, but it would seem that the axon must lay
down more cytoskeleton and membrane or suffer compromised integrity. Adult
neurons also seem to tolerate this axon stretching less well than embryonic
neurons, which could relate to age acquired cytoskeletal modifications or loss of
developmental gene expression programs (Loverde et al., 2011). Still the
concept of stretch-induced growth may be a promising lead for future neural
repair strategies once the mechanism(s) can be uncovered, particularly if this
might complement other growth-promoting strategies.
There are intersections between neural repair, axonal transport, and
neurodegenerative mechanisms that warrant mention. As indicated above, DLK
and SCG10 have dual roles in regeneration and axonal degeneration. The
severed axon has lost its cell body source of proteins, RNPs, and organelles.
Consequently, this severed axon segment needs to survive on existing entities,
or gather what it needs from its local environment (e.g., glia). To some extent,
defects in axonal transport can result in a similar situation. Reduced anterograde
delivery of axonal components produced in the cell body and reduced transport
of signals originating in distal targets can compromise the health of the neuron.
Indeed, transport defects can be a key factor in neurological diseases and
mutations or depletion of motor proteins or their regulators are emerging as
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causative agents in disease. Beyond Huntington’s disease mentioned above,
defects in axon transport in age-related dementias such as Alzheimer’s disease
(Kanaan et al., 2013). The distances that motor axons traverse may make them
particularly vulnerable to transport deficits. Consistent with this notion, a KHC
mutation that disrupts microtubule binding has been found in patients with
hereditary spastic paraplegias, mutations in mouse DHC lead to an ALS-like
motor neuron degeneration (Fichera et al., 2004; Ikenaka et al., 2012) and a
mutation in the p150Glued dynactin subunit has been found in an autosomal
dominant form of lower motor neuron disease (Puls et al., 2003).
Symptoms of neurodegenerative diseases including ALS have been linked
to loss of synapses that may be initiated by ‘dying back’ of the distal axon
(Adalbert et al., 2012). Blocking the degeneration of their axons can prevent the
death of neurons in some neurodegenerative diseases. For example, deletion or
inhibition of DLK is neuroprotective in cellular and animal models of Alzheimer’s
disease, Parkinson’s disease and glaucoma (Ferraris et al., 2013). Expression of
axonally targeted Ube4b-NMNAT1 fusion protein (Wallerian degeneration slow
protein, ‘Wlds’) can delay Wallerian degeneration and prevent neuron loss in
several different animal models of neurodegeneration (Coleman and Freeman,
2010). Delayed degeneration occurs because the Wlds protein maintains
nicotinamide adenine dinucleotide (NAD+) levels in the severed axons. Normally
axons contain NMNAT2 that fulfills the same enzymatic function to maintain
NAD+, but NMNAT2 has short a half-life and must be continually replenished by
anterograde transport (Gilley and Coleman, 2010). If transport becomes
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compromised, the neuron can be placed in the vulnerable position of losing its
axon. Intriguingly, work in ALS animal models pointed to a shift in the
retrogradely transported cargos from ‘pro-survival’ cargos to ‘stress-related’
cargos with increasing severity of neurodegeneration (Perlson et al., 2009). The
similar responses in physical injury of the axon and neurodegenerative diseases
suggest the possibility that neurons in both cases may be mounting, or
attempting to mount, a regenerative response, although few studies have
addressed this possibility. Coordination of several signal transduction pathways
and intracellular trafficking/signaling is needed to mount and maintain a
regenerative response. Small alterations in these pathways could effectively alter
function, growth, and maintenance of the axon.
Axon injury/repair and Lis1
While the bulk of this chapter is a review beyond the scope of the work
I’ve completed during my doctoral degree, it is relevant to some future directions
we are beginning to explore in the lab and covers some of the signaling
pathways involved in regulating transport, which plays a crucial role in axon
regeneration. Specifically, the sections regarding the role of motor proteins in
injury signaling and how transport of cellular components (cytoskeletal proteins,
synaptic proteins, etc.) is critical to regeneration of an injured axon are intimately
related to the work I have published and present in this dissertation.
Additionally, our lab has begun investigating the role of Lis1 in nerve
regeneration. There are multiple aspects of injury and repair that Lis1 may
regulate. First is the retrograde injury signaling – is Lis1 involved in the transport

45

of pSTAT3 and other injury signals from the site of injury to the nucleus?
Additionally, Lis1 and its regulation of dynein could have effects on axon growth
itself through transport of cellular components and its effects on cytoskeletal
dynamics. Indeed, Figure 3.2I in Chapter 3 shows data indicating Lis1 knockout
may disrupt growth of axons from cultured adult DRG neurons. Future
experiments will attempt to determine the mechanism through which this occurs.
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Figure 2.1: Schematic of neural trafficking in mature, injured, and
regenerating axons. A, Schematic of mature axon with proximal on left and
distal on right; microtubules show characteristic polarity with plus ends
oriented distally. With this polarity, kinesin is used for anterograde transport
and dynein is used for retrograde transport. Intermediate filaments and
cortical microfilaments characteristic of the mature axon are not shown here.
B, With injury of the axon, the higher extracellular (Ca2+) results in Ca2+ influx
(1) that triggers membrane sealing, proteolysis, and translation of resident
mRNAs encoding injury-associated gene (IAG) products in axons. Injury
results in a shift in retrograde transport (2), including signaling proteins that
are ‘activated’ locally after injury as well as newly translated proteins
encoded by the some of these IAG mRNAs in axons. Transcription in the
neuronal cell body is altered by this shift in transport resulting in increased
transport of regeneration-associated gene (RAG) products (3) into the
injured axon to support neural repair. C, The repaired end of the injured axon
is transformed into a growth cone that is rich in actin microfilaments and
contains dynamic microtubules that support growth. This figure is adapted
from (Kalinski et al., 2015a).
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CHAPTER 3
AN ESSENTIAL POSTDEVELOPMENTAL ROLE FOR LIS1 IN
MICE2
3.1 INTRODUCTION
LIS1 mutations in humans cause a “smooth brain” mal-formation called
lissencephaly (LIS) characterized by severe cognitive and motor impairments
and worsening epilepsy, leading to early mortality (Dobyns and Das, 1993;
Dobyns et al., 1993; Sapir et al., 1999; Gleeson, 2000; Sicca et al., 2003; Saillour
et al., 2009; Reiner and Sapir, 2013; Herbst et al., 2016). Most of the human
mutations result in a null allele with 50% reduction of LIS1 protein levels, which
profoundly impacts the developing nervous system. Other mutations can produce
a milder phenotype, but the phenotype/genotype correlation is complex. A classic
mouse study made it clear that gene dosage is relevant, as progressive reduction
of Lis1 protein levels caused progressively more severe phenotypes (Hirotsune
et al., 1998). Deletion of a large portion of one Lis1 allele in mice, resulting in a
null allele, delays neuronal migration and differentiation, but unlike humans,
mature mice show mild neurologic abnormalities and are viable and fertile
(Hirotsune et al., 1998; Gambello et al., 2003). Cre-mediated knockout (KO) in
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specific subpopulations of developing neural cells in mice impacts mitosis and
nucleokinesis, causing developmental delay (Tsai et al., 2005; Tsai et al., 2007;
Yingling et al., 2008; Youn et al., 2009; Hippenmeyer et al., 2010).
Lis1 is a highly conserved regulator of the minus-end directed microtubule
motor protein, cytoplasmic dynein 1; together they regulate neural stem cell
spindle orientation, nucleokinesis, and nuclear envelope breakdown during brain
development (Vallee et al., 2001; Wynshaw-Boris and Gambello, 2001; Gambello
et al., 2003; Shu et al., 2004; Tsai et al., 2005; Vallee and Tsai, 2006; Tsai et al.,
2007; Hebbar et al., 2008; Schwamborn and Knoblich, 2008; Yingling et al.,
2008; Youn et al., 2009; Hippenmeyer et al., 2010; Moon et al., 2014). In fact,
mutations in the dynein heavy chain gene DYNC1H1 can also cause cortical
malformations in humans (Vissers et al., 2010; Willemsen et al., 2012; Poirier et
al., 2013).
Of particular interest are reports that DYNC1H1 mutations cause later
onset neurologic disorders, including forms of spinal muscular atrophy (SMA)
and Charcot-Marie-Tooth disease (Weedon et al., 2011; Harms et al., 2012).
Additionally, mutations in genes encoding two other dynein regulators DCTN1
and BICD2, cause Perry syndrome and SMA (Wider and Wszolek, 2008;
Neveling et al., 2013; Oates et al., 2013; Peeters et al., 2013). The extent to
which Lis1 functions post-developmentally, especially in minimally proliferative
tissues like adult brain, has not been studied extensively. Hunt et al. (2012) found
that heterozygous Lis1 KO in six-week-old mice altered synaptic function in the
hippocampus in the absence of altered laminar granule cell architecture, but the
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mechanisms underlying the altered activity are not known (Hunt et al., 2012). It
has been shown that Lis1 manipulations impact dynein-dependent axon transport
in sensory neurons cultured from adult rats (Smith et al., 2000; Pandey and
Smith, 2011). These results suggest that Lis1 is a positive regulator of dyneinbased axon transport in adult mammals. This was also found in adult mouse
DRG neurons (Klinman and Holzbaur, 2015). Although axon transport studies
suggest a role for Lis1 in cultured adult neurons, these neurons do not form
synaptic connections, so its involvement in synapse formation and maturation is
currently unknown. If Lis1 indeed regulates axon transport in the mature nervous
system, Lis1 mutations could have deleterious effects on circuitry in mature
brains. We have addressed this fundamental question using a tamoxifeninducible Cre-Lox system to disrupt Lis1 selectively in adult mice. We show that
Lis1 is indispensable in adult mice, and describe unexpected temporal and
spatial recombination patterns and how they impact the phenotype of Lis1 KO in
adult animals. Our data point to a vital role for Lis1 in cardiorespiratory nuclei in
the hindbrain.

3.2 RESULTS
3.2.1 LIS1 IS EXPRESSED IN ADULT MOUSE TISSUES, PREDOMINANTLY
IN THE NERVOUS SYSTEM

As detected by automated capillary immunoblotting, levels of Lis1 protein
were only modestly lower in adult brain than embryonic brain protein samples
(Fig. 3.1). Substantial Lis1 was also observed in adult spinal cord and dorsal root
ganglia. While Lis1 could be detected in adult heart, liver, kidney, lung, and
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diaphragm, the levels were much lower in all non-nervous tissues tested than in
brain, spinal cord and DRG. Therefore, Lis1 may function in other tissues, but is
either present in fewer cells or at lower amounts per cell.

3.2.2 KO OF LIS1 BY CRE-MEDIATED RECOMBINATION CAUSES AXON
TRANSPORT AND GROWTH DEFECTS IN CULTURED ADULT SENSORY
NEURONS

All mouse strains used in these studies are described in Table 1. To test
the effectiveness of the Act-Cre-ER model for inducing recombination in neurons
and reducing Lis1 expression, DRGs from Lis1 KO mice and the no Cre controls
were dissociated and cells cultured for 24 h. Cultures were treated with 4-OHT
for an additional 72 h. No tamoxifen-induced recombination was observed in the
no Cre control cultures, as detected by prominent tdTomato fluorescence but no
GFP (Fig. 3.2A). In contrast, substantial recombination was observed in the
majority of neurons in the Lis1 KO cultures, detected by the presence of bright
GFP fluorescence (Fig. 3.2B). GFP was observed in both axons and cell bodies.
Also, Lis1 protein levels in extracts prepared from Lis1 KO cultures was greatly
reduced relative to no Cre control cultures (Fig. 3.2C). Together these findings
demonstrate effective KO of Lis1 by bath-applied 4-OHT in cultures of Lis1 KO
mice but not of no Cre controls.
Intraperitoneal injection of tamoxifen into adult Lis1 KO mice also resulted
in recombination in DRGs. For this experiment we injected 8 mg of tamoxifen on
two consecutive days (2 x 8 mg regimen; see Materials and Methods) and
harvested DRGs on day 4 after the first injection. Bright GFP fluorescence was
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observed in neuronal plasma membranes and satellite cells in DRG sections
from these animals (Fig. 3.2D). No GFP was detected in DRGs from no Cre
control animals injected at the same time (data not shown). Dissociated cultures
prepared from no Cre control DRGs showed only tdTomato fluorescence (Fig.
3.2E), while Lis1 KO cultures exhibited bright GFP fluorescence indicative of
substantial recombination (Fig. 3.2F). We first immunostained these cultures for
NF to label axonal processes specifically so that images could be analyzed using
automated software algorithms. However NF immunoreactivity was much more
prominent in axon endings in Lis1 KO axons, possibly reflecting altered NF
transport (Fig. 3.2E, F). Because of this we used the GFP and tdTomato signals
to manually count varicosities. As predicted, the KO neurons had significantly
more varicosities than the no Cre controls (Fig. 3.2G). Although varicosities occur
normally at sites of growth cone pausing or sites of branch formation (Rees et al.,
1976; Malkinson and Spira, 2010) an increased number is often associated with
axonal blockages due to transport defects (Liu et al., 2012). Indeed, reduced
retrograde transport of acidic organelles in living axons was observed in Lis1 KO
axons compared to no Cre controls (Fig. 3.2H) consistent with other studies in
adult rat DRG neurons where Lis1 was depleted using siRNA transfections
(Pandey and Smith, 2011). We also observed that Lis1 KO axons appeared
shorter. To quantify this we measured total axon length per neuron using a
mixture of neuron-specific antibodies to ensure uniform labeling of axons (Fig.
3.2I). On average, Lis1 KO neurons had significantly shorter axons. There were
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also fewer neurons that had extended axons on day 2 after plating, indicating a
delay in the onset of axon regeneration (Fig. 3.2I).

3.2.3 LIS1 KO CAUSES A SEVERE PHENOTYPE IN ADULT MICE
Surprisingly, the 2 8 mg regimen caused a rapid decline in health of Lis1
KO animals, with spinal kyphosis (Fig. 3.3A) and hind leg clasping (Fig. 3.3B)
observed 4 d after the first injection. None of the control animals showed this
phenotype. In early experiments animals died within a week after the first
injection, and mice were subsequently killed as soon as they began to exhibit
symptoms, typically on days 3–5. Animals that were given a different regimen of
tamoxifen, 2 mg injected for five consecutive days (5 x 2 mg regimen), remained
non-symptomatic for nearly two weeks, after which they exhibited similar
symptoms as observed in the 2 x 8 mg regimen. Figure 3.3C shows symptomfree survival duration plots for these animals. No differences were observed
between male and female animals. Most animals were 2 months old at the time
of injection, but similar responses were observed in older animals (4-5 months).
Control animals did not exhibit any symptoms but were typically killed at the
same time as KOs to be able to compare tissues for extent of recombination and
Lis1 expression levels. However, six no Cre control and six CAG-cre/Esr1
animals that received the 2 x 8 mg tamoxifen regimen lived for over a month with
no detectable symptoms (Fig. 3.3C).
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3.2.4 TEMPORAL DIFFERENCES IN TAMOXIFEN-INDUCED RECOMBINATION IN
DISTINCT BRAIN REGIONS OF LIS1 KO MICE

Lis1 KO mice and no Cre control strains were given the 2 8 mg tamoxifen
regimen. As expected, the no Cre control brains only exhibited tdTomato
fluorescence on day 4 after the first injection (Fig. 3.4A, left). In contrast, bright
GFP fluorescence was detected in Lis1 KO mice, but surprisingly, primarily in
midbrain and hindbrain regions, with little fluorescence detected in the cortices
(Fig. 3.4A, right). A similar result was observed in no flLis1 control so the
recombination pattern is similar regardless of whether or not the mice carry the
floxed Lis1 alleles.
Although the severity of the phenotype in Lis1 KO mice prevented
examination of recombination at later times, no flLis1 control animals and Lis1
KO hets remained symptomless for at least three weeks after the 2 x 8 mg
tamoxifen regimen. These animals showed substantial recombination observed
across the entire brain, including the cortex, demonstrating variable rates of
recombination in different brain regions with this 2 x 8 mg tamoxifen regimen
(shown for Lis1 KO het in Fig. 3.4B).
In Lis1 KO mice recombination was observed throughout the medulla pons,
midbrain and cerebellum and into the spinal cord, but only sparsely in the cortex
and hippocampus (Fig. 3.4C). At this level of analysis, the most prominent
recombination in the cerebellum occurs in the molecular layer in linear profiles
reminiscent of Bergmann’s glia. Substantial recombination was also ob-served in
the olfactory bulb and choroid plexus (Fig. 3.4C). GFP-positive cells in the
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brainstem appeared stellate in shape (Fig. 3.4D). White matter tracks in the
brainstem and cervical spinal cord were also GFP-positive (Fig. 3.4E). This GFP
distribution correlates with the reduced Lis1 expression observed in brainstem
and cerebellum but not in cortex (Fig. 3.4F).

3.2.5 LIS1 KO OCCURS IN BOTH NEURONS AND GLIA
In cryosections of Lis1 KO DRGs (2 x 8 mg regimen), recombination was
observed in both neurons and satellite cells (Fig. 3.2C). Membrane-targeted GFP
was observed along neuronal membranes in the brainstem, Purkinje cells in the
cerebellum, and motor neurons in the spinal cord (Fig. 3.5A–F). It was more
difficult to distinguish neuronal processes from glia or axons from dendrites in the
neuropil. Since Lis1 depleted DRGs neurons show altered axon transport and
DRGs cultured from Lis1 KO animals showed signs of altered axon transport, we
examined cross sections of phrenic, vagus, and sciatic nerves, as well as spinal
cord ventral roots. Two concentric rings of GFP were typically observed around
myelinated axons (Fig. 3.5G–J). The outer ring flanked the periphery of the
myelin sheaths (Fig. 3.5I) that stained for myelin basic protein (Fig. 3.5J). GFP
was not observed in the tightly packed myelin sheath itself, so the outer ring
likely represents the plasma membrane of the myelinating glial cell. The inner
ring was juxtaposed along the axoplasmic membrane of the ensheathed axon,
and we interpret this as representing tamoxifen-induced recombination in axons
of Lis1 KO neurons. This interpretation is strengthened by the observation that
only an outer GFP ring was observed in some myelinated axons (Fig. 3.5I),
which would be unlikely if the inner GFP-positive ring was also part of the
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myelinating Schwann cell. Unmyelinated C-fiber bundles in the sciatic nerve are
ensheathed by membranes of Schwann cells that do not form myelin. These
“Remak bundles” can be observed by EM (Fig. 3.5K). Red and green fluorescent
rings were often observed in the same Remak bundles indicating that some, but
not all axons in the Remak bundle had undergone recombination (Fig. 3.5L).
Together these data support the in vitro finding that recombination, and by
inference, Lis1 KO, occurs in both neurons and glia. The preponderance of
recombination in the midbrain, hindbrain, and PNS, coupled with reduction in
Lis1 protein levels in these regions, suggest that Lis1 KO in neurons and glia in
these regions contributes to the observed neurologic phenotypes.

3.2.6 BRAINSTEM NEURONS SHOW CHROMATOLYSIS IN LIS1 KO MICE
Figure 3.6A shows GFP expression in a coronal section through the
hindbrain, with a dense concentration of GFP-positive cells in the ventral
hindbrain. This area contains nuclei that are vital for cardiorespiratory function,
and complete functional loss of these neurons would result in rapid death (Melov
et al., 1998; Quintana et al., 2012). Impairment of axonal transport or other
dynein-dependent processes in this region could account for the severe
phenotype in Lis1 KO animals. Experimental axotomy and diseases that involve
axonal dysfunction can produce the cell body response of chromatolysis (Cragg,
1970; Hanz and Fainzilber, 2006). Though the mechanisms underlying
chromatolysis remain hypothetical, the process is characterized by nuclear
swelling and nuclear acentricity, both of which were observed in GFP-rich
regions in coronal sections through the brainstem of Lis1 KO mice (Fig. 3.6C).
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The nuclei were significantly larger and more acentric than controls providing
evidence for axonal dysfunction in these neurons (Fig. 3.6D–G).

3.2.7 LIS1 LOSS IN THE HINDBRAIN IS THE MOST LIKELY CAUSE OF THE KO
PHENOTYPE

Lis1 KO mice receiving the 2 x 8 mg tamoxifen regimen had a much more
rapid onset of symptoms compared to the 5 x 2 mg regimen (Fig. 3.3C). Indeed,
at a time when the 2 x 8 mg mice were severely affected (day 5), the 5 x 2 mg
animals had no overt symptoms. Substantially more recombination was observed
in the brains of 2 x 8 mg animals compared to 5 x 2 mg animals, which correlates
with the onset of severe symptoms (Fig. 3.7A) and the level of Lis1 mRNA in the
brainstem (Fig. 3.7B). In contrast, recombination in the heart was similar in both
sets of mice (Fig. 3.7C), as were Lis1 mRNA levels, which were reduced equally
with both regimens (Fig. 3.7D). This indicates that Lis1 KO in the heart is less
likely to be responsible for the early onset of symptoms. Other tissues with
sporadic GFP (lung, liver, and kidney) also showed a similar degree of
recombination with both regimens, supporting the idea that the hindbrain loss of
Lis1 contributes significantly to the KO phenotype.
We performed another experiment to directly test contributions of Lis1 KO in
the heart to the phenotype observed in Lis1 KO mice by generating an inducible
KO in which Cre-ER is driven by a Myh6 promotor (Myh6 KO; (Sohal et al.,
2001)). As expected, tamoxifen injections (2 x 8 mg) reduced Lis1 expression in
the heart but not in the brainstem of these mice (Fig. 3.7E). Moreover, robust
GFP expression, and thus Myh6 KO-dependent recombination, was observed in
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the heart, but not in the brain (Fig. 3.7F). Despite significant recombination in the
heart, 0/12 mice showed any detectable phenotype, and all lived apparently
symptom free, until killed four weeks later. Together these data provide evidence
that loss of Lis1 in midbrain/hindbrain neurons is responsible for severe
phenotype in Lis1 KO mice.

3.3 DISCUSSION
We show that Lis1 KO by tamoxifen-induced recombination causes
neuropathology and lethality in adult mice. The finding that Lis1 continues to play
a vital role after the majority of mitosis and migration in the brain has occurred
supports the idea that Lis1 regulates additional cellular processes such as axonal
transport. Given the preponderance of evidence that Lis1 regulates cytoplasmic
dynein coupled with the observed temporal and spatial pattern of Cre-mediated
recombination, the simplest explanation for the severe phenotype caused by Lis1
depletion is that defective axon transport results in pathologic changes in
midbrain, hindbrain, spinal cord, and DRG neurons. That these areas are critical
to the phenotype is supported by the correlation between the location and extent
of recombination (and thus Lis1 loss), and the onset of symptoms using different
tamoxifen dosing regimens. At the onset of severe neurologic symptoms (4 – 5 d)
the 2 x 8 mg tamoxifen regimen produced substantial recombination in cells in
those regions. At the same time point in animals exposed to the 5 x 2 mg
tamoxifen regimen no symptoms were present and much less recombination was
observed in these areas. Unlike the nervous system, other tissues (heart, lung,
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liver, kidney) had a similar degree of recombination using both regimens, arguing
for an important nervous system contribution to the Lis1 KO phenotype. This is
further supported by evidence of chromatolytic neurons in the brainstem and
axon transport defects and varicosities in DRG neurons cultured from Lis1 KO
mice. Axons of the vagus, phrenic, sciatic nerves and ventral roots contained the
Cre reporter (GFP) indicating that recombination had occurred in neurons. Lis1
depletion in neurons with axons running in those nerves could contribute to the
Lis1 KO phenotype. For example the vagus nerve contains autonomic axons
emerging or converging on the nucleus ambiguous, solitary nucleus, dorsal
nucleus of vagus, and spinal trigeminal nucleus, and is critical for
cardiorespiratory control. The phrenic nerve contains sympathetic, sensory and
motor axons innervating the diaphragm, mediastinal pleura, and pericardium.
Brainstem perturbations in animals can lead to death due to cardiorespiratory
disruption (Talman and Lin, 2013; Piroli et al., 2016; Sun et al., 2017). Thus, the
idea that Lis1 KO in brainstem neurons is a lethal event in mice is not too
farfetched.
Sensory and motor neurons with axons in the sciatic nerve are less likely
to contribute to the death of the animals, but may contribute to the leg clasping
and kyphosis observed in 100% of Lis1 KO mice. Also, the finding that axon
growth by DRG neurons in culture is compromised by Lis1 depletion indicates
that peripheral nerve regeneration in vivo could be affected by changes in Lis1
expression. The role of microtubule motors in developmental axon growth and
axonal regeneration after injury is complex. In some studies, motor activity
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appears to be a negative regulator of growth. Retrograde target derived signals
prohibit growth in mature connected neurons (Smith and Skene, 1997).
Transport-dependent length-sensing signals have an inverse relationship with
axon length, in those studies dynein or kinesin knockdown or a specific dynein
mutation caused adult DRG axons to be longer (Kam et al., 2009; Rishal et al.,
2012). Finally, stimulation of dynein by a BICD2 mutation resulted in shorter
axons in cultured hippocampal neurons (Huynh and Vale, 2017).
On the other hand, there are also many studies that indicate that both
anterograde and retrograde signals promote regenerative growth (Mar et al.,
2014; Kalinski et al., 2015b). For example, a pro-growth injury signal that is
required for axonal regeneration in the sciatic nerve requires retrograde transport
by dynein (Ben-Yaakov et al., 2012). Dynein can push the cytoskeleton forward
during axon initiation and elongation in developing axons (Dehmelt et al., 2006;
Roossien et al., 2014), and DHC knockdown reduced microtubule movements
into growing axons and stunted axon outgrowth in cultured adult PNS neurons
(Ahmad et al., 2006). While our data focused on regeneration of adult axons,
others have also found that depletion of Lis1 leads to decreased developmental
axon growth (Grabham et al., 2007; Kumamoto et al., 2017). Taken together,
these data suggest that Lis1 knockdown could reduce transport of regenerative
signals and also disrupt dynein-dependent cytoskeletal changes required for
axon growth. Because Lis1 overexpression stimulated dynein-dependent
organelle transport (Pandey and Smith, 2011), it will be interesting to determine
whether Lis1 overexpression also negatively impacts axon growth.
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While it is critical to know the organs, tissues and cells that contribute to
the severe Lis1 KO phenotype, it is equally important to determine which are less
affected by Lis1 depletion. With respect to the midbrain/hindbrain, spinal cord,
and DRG neurons, we cannot state that some neuronal subtypes are more
affected by Lis1 KO than others, and in fact, suspect that disruption in all of them
could be a contributing factor to the phenotype, as suggested above. With
respect to other brain regions, including the cerebral cortex, hippocampus,
striatum, pallidum, and hypothalamus, Lis1 KO animals died before significant
recombination occurred in these regions. However, we expect that Lis1 is
important in all axons; signs of pathology may have become apparent in these
regions had Lis1 KO animals survived long enough for recombination to occur.
Our heterozygous Lis1 KO animals exhibited substantial recombination in all
brain regions by three weeks after 2 x 8 mg tamoxifen injection but did not exhibit
leg clasping, kyphosis or lethality. It remains to be determined whether signs of
axonal dysfunction will arise in cortical regions of heterozygous Lis1 KO mice as
animals age. Another group used a similar inducible system to examine
hippocampal function following heterozygous Lis1 KO in six-week-old mice (Hunt
et al., 2012). They found an increase in excitatory synaptic input to granule cells
in the absence of neuronal positioning defects. The molecular and cellular
underpinnings of this are not known, but our data suggest that it might involve
axonal transport disruption. In our study, a much more limited Lis1 depletion was
accomplished by stereotaxic injections of 4-OHT into lateral ventricles. This did
not produce any obvious symptoms (leg clasping, kyphosis or death) probably
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because recombination had occurred very sparsely and mainly in glial cells (data
not shown). Ultimately, more selective examination of the role of Lis1 in adult
neuronal circuits will require using Cre-driver(s) specific for different neuronal
populations. Some glial cells exhibited Cre-mediated recombination in our Lis1
KO mice. Glial cells in cortical, hippocampal and DRG cultures express Lis1
(Smith et al., 2000), and there was substantial recombination in Bergmann’s glia,
astrocytes and Schwann cells, so depletion of Lis1 in any of these cells could
theoretically contribute to Lis1 KO phenotypes. Glial specific Lis1 KO may allow
us to answer this question.
With respect to other tissues in the mouse, we can state unequivocally
that the severe Lis1 KO phenotype was not due to Lis1 depletion in
cardiomyocytes. Depletion in liver, lung, and kidney was likely highly mosaic at
the time when symptoms were severe because recombination was sparse in
these tissues, and was similar on day 5 using both tamoxifen regimens. Thus,
while our data suggest that Lis1 depletion in these tissues does not produce the
rapidly lethal phenotype, to fully answer this question, we will need to use organ
or cell specific Cre-ER drivers.
While our studies unequivocally demonstrate a vital role for Lis1 in adult
mice and strongly support a role in axon transport, Lis1 and dynein both function
in dendrites, at least during development. For example, dynein-based transport
occurs in dendrites in rodent hippocampal cultures (Kapitein et al., 2010; Ayloo et
al., 2017), and signs of transport defects are observed in motor neurons in the
adult Loa dynein mutant mouse (Wiggins et al., 2012).
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Interestingly, Lis1 knockdown by shRNA expression disrupted the
translocation of excitatory synapses in developing interneuron dendrites in
hippocampal cultures and organotypic slices (Kawabata et al., 2012). Moreover,
two-photon microscopy showed altered spine morphology dynamics in threeweek-old Lis1 mice (Sudarov et al., 2013). Together, these reports suggest that
Lis1 dysfunction in dendrites in the midbrain, hindbrain, and spinal cord could
contribute to the Lis1 KO phenotypes.
Uncovering a role for Lis1 in axonal or dendritic transport in post-mitotic,
connected neurons is interesting for several reasons. First, if axonal transport is
compromised in LIS, it could contribute to the seizures (which become
increasingly frequent and severe) and the early lethality typical of the disorder.
Axon transport defects, unlike defects that arise because of brain malformations
that occur in utero, might be ameliorated with drugs that target the dynein
regulatory machinery. Second, dynein-related proteins are linked to many
neurodegenerative diseases (Rees et al., 1976; Wider and Wszolek, 2008;
Weedon et al., 2011; Harms et al., 2012; Neveling et al., 2013; Oates et al.,
2013; Peeters et al., 2013). In fact, respiratory problems in the late-onset
disorder, Perry Syndrome, are the cause of lethality in humans (Wider and
Wszolek, 2008). To treat such disorders, it is critical to understand the
mechanisms regulating dynein in axons. In most cell culture studies, Lis1
overexpression stimulated, and Lis1 disruption reduced processivity (Liu et al.,
2000; Smith et al., 2000; Pandey and Smith, 2011; Shao et al., 2013; Klinman
and Holzbaur, 2015; Villarin et al., 2016). However, one transport study indicated
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that Lis1 knockdown increased mitochondrial transport (Vagnoni et al., 2016),
and several in vitro biophysical studies showed that Lis1 inhibited processivity of
purified dynein (Yamada et al., 2008; McKenney et al., 2010; Huang et al., 2012).
More recent assays using purified proteins are beginning to reveal how this might
occur at the molecular level in the context of other dynein regulators like dynactin
and BICD2 (Baumbach et al., 2017; DeSantis et al., 2017; Gutierrez et al., 2017).
In those studies, Lis1 dramatically increased dynein processivity. Interestingly
BICD2 mutations that cause SMALED stimulate dynein processivity, so motor
activity must be finely tuned (Huynh and Vale, 2017). Kinase pathways that
impact dynein function have been identified. CDK5, mutations in which have
been linked to LIS (Magen et al., 2015; Parrini et al., 2016) and other kinases
phosphorylate and regulate the Lis1- and dynein-interacting protein Ndel1
(Hebbar et al., 2008; Pandey and Smith, 2011). Phosphorylation also regulates
motors directly (Gibbs et al., 2015). We recently reported that insulin-dependent
inhibition of GSK3b, a kinase with a growing list of neurologic disease links
(Dell'Osso et al., 2016), phosphorylates dynein and regulates its interactions with
Ndel1 and APC (Gao et al., 2015; Gao et al., 2017). It will be interesting to
determine whether these pathways can be manipulated to alter the severity of
the Lis1 KO phenotype, and if they can be used in trying to alleviate symptoms of
patients with diseases caused by transport defects.
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3.4 MATERIALS AND METHODS
Mice
All animal experiments were conducted under a protocol approved by the
Animal Care and Use Committee of the University of South Carolina. Males and
females were used in experiments; no differences were observed in outcomes
between males and females. Four mouse strains were used to generate the
inducible Lis1 KO mice (Table 3.1). (1) 129S-Pafah1b1tm2Awb/J (The Jackson
Laboratory 008002, RRID:IMSR_JAX:008002): loxP sites flank exons 3 – 6.
Homozygous mice are viable and fertile, but have mild hippocampal
abnormalities and express 75% of WT Lis1 levels (Hirotsune et al., 1998); (2)
Tg(CAG-cre/ Esr1 )5Amc/J (The Jackson Laboratory 004453, RRID:
IMSR_JAX:004453), a chicken β-actin promotor drives expression of Cre
recombinase fused to a modified estrogen receptor; (3) Tg(Myh6cre/Esr1)1Jmk/J (The Jackson Laboratory 005650, RRID:IMSR_JAX:005650),
expression of Cre-ER is under the control of a cardiac-specific a-myosin heavy
chain promoter so that tamoxifen stimulates recombination only in cardiac cells;
and (4) Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J (The Jackson
Laboratory 007576, RRID:IMSR_JAX:007576), a Cre re-porter mouse with loxP
sites flanking a membrane-targeted tdTomato cassette that is positioned
upstream of a membrane-targeted EGFP cassette. All cells in these mice exhibit
membrane-associated red fluorescence until the tdTomato cassette is deleted by
Cre recombinase for expression of membrane-associated EGFP fluorescence,
allowing visualization of both recombined and non-recombined cells in the same
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tissue (Muzumdar et al., 2007). Table 3.1 shows the crosses that were used to
generate experimental animals, and shows the descriptive names used for each
throughout the chapter. All strains used in experiments were homozygous for the
Cre reporter. Genotyping of all animals was performed using primers and
protocols recommended by The Jackson Laboratory. Primers are available on
request.
Tamoxifen administration
Numbers of animals are provided below (Experimental design and
statistical analysis). Tamoxifen was delivered by intraperitoneal or
intracerebroventricular injections in adult mice (two to five months old). For
intraperitoneal delivery, mice were injected with 40 mg/ml tamoxifen (SigmaAldrich) dissolved in 10% ethanol and 90% corn oil (Sigma). Two different daily
tamoxifen dosage regimens were tested based a previous study using this CreER strain (Hayashi and McMahon, 2002): regimen 1 (5 x 2 mg), 2 mg for five
consecutive days (total 10 mg); and regimen 2 (2 x 8 mg), 8 mg injected on two
consecutive days (total 16 mg). For intracerebroventricular delivery, mice were
anesthetized with an isoflurane/oxygen vapor mixture (5% induction, 2–3%
maintenance) and placed in a stereotaxic device (Kopf Instruments). Five
microliters of 50 mM (Z) 4-hydroxytamoxifen (4-OHT; Sigma) dissolved in 100%
ethanol was infused into the left lateral ventricle at a rate of 0.4 ml/min using a 5
ml Hamilton syringe. The needle was left in place for one additional min before
removal to allow for diffusion from the injection site. Coordinates (-1.0 mm
posterior from Bregma, 1.0 mm mediolateral, and -2.5 mm ventral to skull
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surface) were determined using the atlas of Paxinos and Franklin (Franklin and
Paxinos, 2001).
Analysis of Cre-mediated recombination by tdTomato/EGFP fluorescence
Images shown in all figures are representative of data acquired from at
least N = 3 animals per experiment. Animals under deep isoflurane anesthesia
were perfused transcardially with ice-cold PBS, followed by 4%
paraformaldehyde (PFA) in 0.1 M PBS (pH 7.4). Before sectioning, tissues were
cryoprotected by immersion overnight in 15% sucrose, followed by 24 h in 30%
sucrose in PBS. Tissues were then frozen in OCT compound (Fisher) using a
beaker of 2-methylbutane chilled in dry ice. Ten- or 50-mm-thick cryosections
were stored at 80°C until use. Whole brains and hearts were imaged immediately
after dissection using an Olympus SZX-12 with an SZX-RFL2 coaxial
fluorescence attachment. Cryosections were imaged using a Leica TCS SP8X
confocal microscope equipped with LAS X software and a 63 oil immersion
objective (1.4 N/A). Some images were obtained using a Zeiss Axiovert 200
inverted microscope equipped with AxioVision software and a Plan-Neo 100 Å
/1.30 and Plan-Apo 63 Å /1.40 oil-immersion objectives (Immersol 518F; Carl
Zeiss, Inc.) or a Plan-Neofluor 20 dry objective.
Protein isolation and immunoblotting
All blots are representative of at least N = 3 repeats. Tissues were
dissected quickly from CO2-killed mice and frozen in liquid nitrogen, followed by
Dounce homogenization in ice-cold RIPA lysis buffer with protease and
phosphatase inhibitors (Thermo). Total protein in extracts was determined using
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a BCA assay (Thermo). Automated capillary electrophoresis and immunoblotting
(Figs. 3.1, 3.2) was performed with the Wes Simple Western system using the
manufacturer’s protocol (Protein Simple). One microgram of lysate was loaded
for each sample. Anti-mouse (ERK1), anti-rabbit (Lis1), and total protein
detection modules were used per manufacturer’s instructions. Blots were
analyzed using Compass Software (Protein Simple). For traditional Western
blotting (Figs. 3.4, 3.7) 10 mg of each sample were separated on 10%
acrylamide gels, then transferred to PVDF membrane. Blots were probed with
antibodies against Lis1 and dynein intermediate chain and proteins were
detected by chemiluminescence.
Sciatic nerve transmission electron microscopy
While anesthetized with isoflurane, WT mice were perfused with PBS, and
then buffered 2.5% glutaraldehyde. Nerves were removed and fixed overnight in
2.5% glutaraldehyde, then sectioned and stained with osmium tetroxide for
imaging on a JEOL 200CX Transmission Electron Microscope.
Antibodies
Primary antibodies used are as follows: Lis1 rabbit polyclonal 484/485
(Smith et al., 2000; WB: 1:500); Lis1 rabbit polyclonal (Wes: 1:25, WB: 1:500;
Santa Cruz Biotechnology sc-15319, RRID:AB_2159891); ERK1 rabbit
polyclonal (Wes: 1:100; Abcam ab109282, RRID: AB_10862274); a mix of the
pan-axonal neurofilament (NF) mouse monoclonal cocktail (IF: 1:500; BioLegend
837904, RRID:AB_2566782); NF light, medium, and heavy chain chicken
polyclonals (IF: 1:500; Aves NFL, NFM, and NFH, RRIDs: AB_2313553,

68

AB_2313554, AB_2313552); and the NF 200-kDa mouse monoclonal, clone
RT97 (IF: 1:500; Millipore CBL212, RRID:AB_93408) were used to label NFs;
GAP43 rabbit polyclonal (IF: 1:500; Novus Biologicals, NB300-143, RRID:
AB_10001196); beta-III tubulin chicken polyclonal (IF: 1:500; Millipore AB9354,
RRID:AB_570918); peripherin chicken polyclonal (IF: 1:500; Abcam ab39374,
RRID:AB_777207); choline acetyl-transferase goat polyclonal (IF: 1:100;
Millipore AB144P, RRID:AB_11214092); MAP2 chicken polyclonal (IF: 1:100;
Abcam ab5392, RRID:AB_2138153); myelin basic protein chicken polyclonal (IF:
1:500; Aves MBP, RRID:AB_2313550); a-tubulin mouse monoclonal (WB:
1:2000; Sigma-Aldrich T5168, RRID:AB_477579); and dynein intermediate chain
mouse monoclonal (WB: 1:1000; Santa Cruz Biotechnol-ogy sc-13524,
RRID:AB_668849). Secondary antibodies used: HRP-conjugated goat anti-rabbit
and mouse (WB: 1:50 000; Millipore 12-348 and 12-349, RRIDs: AB_390191 and
AB_390192); Cy5-conjugated donkey anti-chicken, mouse, and goat (IF: 1:250;
Jackson ImmunoResearch 703-175-155, 715-175-150, and 705-175-147,
RRIDs:AB_2340365, AB_2340819, and AB_ 2340415); and DyLight 405conjugated donkey anti-chicken (IF: 1:250; Jackson ImmunoResearch 703-475155, RRID: AB_2340373).
Preparation of DRG cultures
Cultures were generated from two- to five-month-old Lis1 KO and no Cre
or no flLis1 control mice. In some experiments mice were exposed to the 2 x 8
mg tamoxifen intraperitoneal regimen then neurons harvested on day 4 after the
first injection. In other experiments, 4-OHT (2 μM) was added directly to the DRG
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cultures with these same genotypes without previous intraperitoneal injections.
DRGs were harvested (20 per mouse), dissociated in type XI collagenase
(Sigma) for 1 h at 37°C, and then triturated through a flamed Pasteur pipet.
Dissociated neurons incubated in 0.05% trypsin (Invitrogen) at 37°C for 15 min.
After a second trituration, cell suspensions were centrifuged through a 12.5%
BSA solution to remove myelin fragments. Cells were then plated onto sterile,
German glass coverslips (Fisher) coated with 10 mg/ml poly-D-lysine (300 kDa;
Sigma) and 10 mg/ml laminin (Millipore). Cells were cultured in DMEM/F12
medium (Corning) with 25 mM HEPES, GlutaMAX (Thermo Fisher), N-2
supplement (Life Technologies), and 10% horse serum (HyClone). In some
experiments, 100 mM cytosine arabinoside was added to reduce non-neuronal
cell proliferation.
Axonal varicosity analysis
DRG neurons obtained after intraperitoneal injection were maintained in
culture for 4 d and then fixed for 10 min in 4% PFA. Coverslips were mounted on
glass slides using Prolong Gold Antifade (LifeTechnologies). Neurons were
imaged using the ImageXpress XLS high content imaging system (Molecular
Devices) equipped with a 20 objective. A segmented line (one-pixel width) was
used to trace the axon using ImageJ software. Axonal swellings that protruded
visibly beyond the one-pixel line on both sides were counted as varicosities.
tdTomato-positive axons from N = 3 no Cre cultures (45 mm of total axon length)
and EGFP-positive axons from N = 3 Lis1 KO cultures (27 mm of total axon
length) were measured.
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Axon growth/length analysis
DRG neurons obtained after intraperitoneal injection were maintained in
culture for 2 d and then fixed for 10 min in 4% PFA. Neurons were processed for
immunofluorescence using a cocktail of neuron-specific antibodies: chicken antiperipherin, chicken anti-b III tubulin, chicken anti-NF (light, medium, and heavy
chains), and rabbit anti-GAP43 to ensure all axons were uniformly labeled.
Neurons were imaged using the ImageXpress Micro XLS system and axon
lengths were measured using WIS-Neuromath software. N = 5 Lis1 KO mice, and
N = 4 no flLis1 control mice were analyzed; n = 122 control and n = 70 KO
neurons were measured.
Organelle movement
Cultured DRG neurons obtained after intraperitoneal injection were
exposed to 100 nM Lysotracker-Red (Millipore Inc.) for 20 min. Coverslips were
transferred into fresh medium containing OxyFluor (Oxyrase Inc.) and 25 mM
HEPES (pH 7.4), and placed in a custom-built water-heated microscope stage
warmed to 37°C. Organelles were imaged using a Zeiss Axiovert 200 microscope
equipped with a C-Apo 63x /1.2 W/0.2 water-immersion objective. Images were
acquired at 0.5-s intervals for 2 min using a Zeiss AxioCam HRm charge-coupled
camera and linked AxioVision 4.7 software. Kymographs were generated from
time-lapse movies using ImageJ soft-ware. N 2 mice of each genotype were
analyzed, with a total of 27 axon segments analyzed from each genotype. A total
of n 521 no flLis1 control and n 699 Lis1 KO organelles were included. Direction
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of movement was determined by locating the cell body before imaging. Net
displacement of 5 μm toward the cell body was categorized as retrograde.
Immunofluorescence in DRG cultures and tissue cryosections
Immunofluorescence experiments were performed in triplicate (N = 3 mice
per genotype) and representative images are shown in the figures. After
permeabilization with 0.1% Triton X-100 for 10 –30 min, samples were blocked in
3% BSA (Fisher), 10% normal goat serum (Sigma), and 0.2% Tween 20 (BioRad) in PBS for 1 h. Cultures and nerve sections were exposed to primary
antibodies for 1 h at room temperature. Brain and spinal cord sections were
exposed to primary antibody over-night at 4°C. In both cases samples were
exposed to fluorophore-conjugated secondary antibodies for 1 h at room
temperature. Nuclei were stained with Hoechst dye and samples mounted using
Prolong Gold.
Quantifying chromatolysis in brainstem sections
Animals were exposed to the 2 x 8 mg tamoxifen regimen. On day 4,
coronal cryosections of brainstem from N = 3 no flLis1 control mice (n = 331
neurons) and N = 4 Lis1 KO mice (n = 583 neurons) were stained with 1%
toluidine blue and measured for nuclear enlargement and nuclear acentricity. The
Allen Mouse Brain Atlas was used as a guide to select coronal brainstem
sections in which the nucleus ambiguus and other cardiorespiratory centers were
likely located. Landmarks such as the fourth ventricle and pyramus granular
layers were used to identify the proper sections. Comparisons were made from
matched sections. Substantial Act-Cre-ER mediated re-combination (GFP
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expression) was consistently observed in similar sections following tamoxifen
administration. ImageJ was used to determine nuclear and somal areas and
centroids. The ratio of the nuclear area to the somal area was calculated to
establish a “nuclear enlargement index.” A “centroid displacement index” was
calculated by summing the X and Y displacement differences between the
nuclear centroid and the somal centroid of each cell.
RNA extraction and analysis
RNA analysis was performed using tissues from 3 mice per treatment and
genotype. RNA was isolated from flash frozen tissues using the QIAGEN
RNAEasy kit per the manufacturer’s instructions. RNA concentration was
determined by fluorimetry using Ribogreen reagent (Thermo Fisher). A total of
100 ng RNA was reverse transcribed with a SensiFast cDNA Synthesis kit
(Bioline). These cDNAs were used for quantitative droplet digital PCR (ddPCR)
with Evagreen detection reagent and ddPCR Supermix (Bio-Rad). Droplets for
ddPCR were made using a QX200 Droplet Generator (Bio-Rad). Results were
analyzed using Poisson distribution on the QX200 Droplet Reader. Mouse Lis1
primer sequences (forward, 5’ GCGAACTCTCAAGGGCCATA 3’ and reverse, 5’
CATTGTGATCGTGACCGTGC 3’) were designed using NCBI BLAST (NCBI
accession #NM_013625). Mouse b2 micro-globulin (B2M) primers (forward, 5’
TTCTGGTGCTTGTCTCACTGA 3’ and reverse, 5’ CAGTATGTTCGGCTT
CCCATTC 3’) were obtained from Harvard Primer Bank (B2M; NCBI accession
#NM_009735; https://pga.mgh. harvard.edu/primerbank/).
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Experimental design and statistical analysis
Eighty-four Lis1 KO animals were given the 2 x 8 mg tamoxifen regimen;
100% of these animals began to exhibit neurologic symptoms (leg clasping,
kyphosis, decreased motility) within a week. Of these, 18 died during that time,
and 66 were killed when symptoms became severe; 38 no flLis1 control and 73
no Cre control mice were also given the 2 x 8 mg tamoxifen regimen. None of the
controls showed any evidence of neurologic disorder or malaise, but most were
killed at the same time as the Lis1 KO animals to compare results. However, six
each of the control strains were monitored for four weeks after 2 x 8 mg
tamoxifen and showed no symptoms. We also conducted mock injections of
vehicle alone in 12 Lis1 KO animals. These controls also showed no symptoms.
Table 3.2 describes the statistical methods used for all quantified
experiments. The p-values were obtained using Excel or GraphPad Prism 5.
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Table 3.1: List of mouse strains used in Chapter 3.

Founder mouse lines
Jackson Labs strains
129S-Pafah1b1

tm2Awb

Descriptive name used in paper

/J

Lis1

LoxP/+

or Lis1

LoxP/LoxP

Tg(CAG-cre/Esr1*)1Jmk/J

Act-Cre-ER (heterozygous)

Tg(Myh6-cre/Esr1*) 1Jmk/J

Myh6-Cre-ER (heterozygous)

Gt(ROSA)26Sor

tm4(ACTB-tdTomato, -EGFP)Luo

/J

Cre Reporter (heterozygous)

All strains below are homozygous for the Cre Reporter
Lis1 KO strains
Lis1
Lis1

LoxP/LoxP

LoxP/LoxP

Descriptive name used in paper

x Act-Cre-ER (het)

Lis1 KO

x Myh6-Cre-ER (het)

Myh6 KO

Control strains

Descriptive name used in paper

Act-Cre-ER

No flLis1 Control

Lis1LoxP/LoxP

No Cre Control

Lis1

LoxP/+

x Act-Cre-ER

Lis1 KO Het

Table 1: Mouse strains and crosses used in these studies
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Table 3.2: Table of statistical tests used in Chapter 3 figures.

Description

Data
Structure

Type of Test

Statistical Value

Axonal varicosities

NonNormal

Mann-Whitney
test

p < 0.0001

Retrograde transport

Normal

t-test

t(52) = 7.746, p = 3.2 x
10-32

c

Nuclear Enlargement
Index

Normal

t-test

t(912) = 19.55, p = 3.6 x
10-73

d

Centroid Displacement
Index

NonNormal

Mann-Whitney
test

p < 0.0001

Lis1 mRNA in
brainstem

Normal

ANOVA

F(2, 19) = 5.033, p =
0.0176

Lis1 mRNA in heart

Normal

ANOVA

F(2,16) = 19.065, p =
5.83 x 10-5

a
b

e
f

Table 2: Statistical table.

Figure 3.1: Lis1 protein is expressed in adult mouse tissues. A total of 1 µg of
tissue lysates was analyzed using the Wes Simple Western System. Brain extracts
from E19 were loaded as a positive control. All other extracts are from two-month-old
animals. The size-based separation is processed by Compass software and
displayed as virtual blots/gels. A, Immune detection of Lis1 in protein samples,
depicted in a virtual immunoblot generated by the system. B, Total protein detection,
visualized by a virtual Coomassie gel generated by the system. These blots are
representative of three experimental repeats (N = 3).
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Figure 3.2: Lis1 KO impacts axonal function in adult mouse DRG neurons. A, Cultured DRG neurons from no
Cre control exposed to 4-OH tamoxifen for 5 d expressed only tdTomato (red) showing no signs of recombination.
B, In contrast, Lis1 KO neurons had strong GFP expression (green) demonstrating recombination. C, 4-OH
tamoxifen reduced Lis1 protein levels in Lis1 KO neurons relative to no Cre control neurons (CON). D,
Intraperitoneal injection of 2 x 8 mg tamoxifen in Lis1 KO mice resulted in GFP expression in intact DRGs after 4 d.
Arrows point to DRG plasma membranes. E, Cultured DRG neurons prepared from intraperitoneally injected, no
Cre control animals expressed only tdTomato (red). NF (blue) was prominent along axon shafts (white arrow) but
less prominent in axon terminals (arrowhead). F, DRG neurons prepared from intraperitoneally injected Lis1 KO
mice continued to express GFP (green) in culture, and NF (blue) was most prominent in distal axons and enriched
in in varicosities (arrow). G, Insets from E, F have been digitally enlarged to show axonal varicosities (arrows). The
bar graph in G shows the average number of varicosities per 100 µm of axon from N = 3 CON (45 mm total axon
length) and three Lis1 KO (27 mm total axon length) mice. H, Kymographs were generated from time-lapse movies
of LysoTracker labeled organelles in GFP-positive axons. The bar graph shows the percentage moving retrogradely
in Lis1 KO and no flLis1 control cultures (CON). A total of 27 100 µm axon segments were analyzed from N = 2
CON and N = 2 Lis1 KO mice. A total of n 521 control and n 699 KO organelles were analyzed. I, Cultured DRG
neurons prepared from intraperitoneally injected, no flLis1 control and Lis1 KO mice were immunostained with
neuron-specific antibodies, and the percentage of neurons with growing axons was determined from N = 4 CON
and N = 5 Lis1 KO mice. A total of n = 2219 control neurons and n = 2410 Lis1 KO neurons were analyzed. Bars in
G-I indicate mean SD. Significance determined by Mann–Whitney test (G), Student’s t test (H, I), p 0.05, p 0.001
(see Table 3.2 for details). Scale bars: 20 µm (A, D, E), 5 µm (B), and 50 µm (I).
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Figure 3.3: Lis1 KO via intraperitoneal tamoxifen injection in adult mice results
in a severe phenotype. Lis1 KO mice exposed to tamoxifen invariably displayed
spinal kyphosis (A, lower panel) and hind leg clasping (B, right panel). Neither was
observed in control animals (CON) at any time. This includes the no Cre, no flLis1,
Lis1 KO het, or mock-injected Lis1 KO animals. Both Lis1 KO and control mice were
killed as soon as kyphosis and leg clasping became apparent in the KO animals.
Phenotypes arose with latencies depending on the specific tamoxifen-dosing regimen
(see Materials and Methods). C, Symptom-free survival curves show that the latency
is shorter for the 2 x 8 mg regimen (N = 84) compared to the 5 x 2 mg regimen (N =
12). Control mice were killed at the same time as the Lis1 KO mice for recombination
and expression studies. However, six no Cre control mice and six no flLis1 control
mice receiving the 2 x 8 mg dosing regimen survived symptom free for three weeks
before they were killed (total N = 12).
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Figure 3.4: Cre-dependent recombination in the brain after tamoxifen injection.
All data in this figure are representative of observations from a minimum of N = 4
animals of each genotype. A, On day 5 after the 2 x 8 mg tamoxifen regimen, no Cre
control brains (CON, day 5) had bright tdTomato fluorescence (top left panel), but no
EGFP fluorescence indicative of recombination (lower left panel). Lis1 KO mice (Lis1
KO, day 5) showed reduced tdTomato fluorescence (top right panel) and expressed
EGFP primarily in the hindbrain, indicating that Cre activity was pronounced in this
brain region (lower right panel). B, Lis1 KO het mice [Lis1 KO (Het), day 21], which
showed no sign of neurological problems through day 21 after the injection had
substantial EGFP expression throughout the brain at that time. C, A sagittal section
of a Lis1 KO brain on day 5 (Lis1 KO, day 5) shows mosaic recombination in
midbrain (white arrow), hindbrain (magenta arrow), and cerebellum (blue arrow),
with widely scattered EGFP-positive cells in cortex and hippocampus.
Recombination also occurs in olfactory bulb (asterisk). D, Using higher
magnification, GFP-positive cells in the midbrain can be seen interspersed with cells
that have not yet undergone recombination. E, Fibers labeled with GFP are clearly
visible in the brainstem. F, Lis1 expression is reduced in extracts from brainstem
and cerebellum of Lis1 KO mice compared to no Cre controls. Scale bars: 5 mm (A–
C), 100 µm (D), and 20 µm (E).
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Figure 3.5: Both neurons and glia show evidence Cre-dependent recombination. All data in this figure are
representative of observations from a minimum of N = 4 animals of each genotype. A, GFP-positive neuropil
surrounds MAP2-positive neurons (magenta) in a brainstem region thought to be the nucleus ambiguous in a mouse
exposed to the 2 x 8 mg tamoxifen regimen. B, The neuron indicated in A has been digitally enlarged to show
details. The arrow points to possible neuronal plasma membrane. C, Purkinje cells in the cerebellum stained with
MAP2 (magenta) also have GFP-positive plasma membranes (white arrow) indicating that recombination occurred
in these neurons. Neuropil in the molecular layer is also GFP-positive (arrowhead). D, The neuron in C has been
digitally enlarged to show detail. E, GFP-positive neuropil surrounds a motor neuron (white arrow) labeled with
ChAT (red) in the anterior horn of the thoracic spinal cord. GFP-positive fibers (arrowhead) can be seen coursing
toward the ventral root. F, The motor neuron indicated in E is digitally enlarged to show detail. The white arrow
points to apparent neuronal plasma membrane. G, A cross section through the phrenic nerve shows concentric
rings of GFP around approximately half of the NF-positive axons (red). H, EM of a cross section through a WT
mouse nerve showing myelinated axons. I, GFP can be observed as two concentric rings or single rings (arrows,
outer ring, arrowhead, inner ring). J, The area between concentric rings is positive for myelin basic protein (blue),
while the inside of the inner ring is positive for NF (red). K, EM of a cross section of WT mouse sciatic nerve
showing Remak bundles of unmyelinated axons surrounded by a single glial cell (red arrow). L, Cross section of
sciatic nerve from Lis1 KO mouse with a Remak bundle containing some GFP-encircled axons, and some without
encircling GFP (arrow, positive for tdTomato only). Inset is digitally enlarged to show an axon without recombination
(red, arrow) alongside recombined axons (green). Scale bars: 10 µm (A, C, G), 30 µm (E), and 2 µm (H–L).
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Figure 3.6: Brainstem neurons in Lis1 KO mice exhibit signs of chromatolysis.
A, A coronal section through the hindbrain on day 4 after the 2 x 8 mg tamoxifen
regimen shows extensive recombination in the ventral brainstem containing
cardiorespiratory centers. White circles indicate the region used in the analyses of
chromatolysis. B, C, Sections were stained with toluidine blue to determine the size
and position of the nucleus in neurons in the indicated regions. The neurons in B are
from a no flLis1 control mouse. The neurons in C are from a Lis1 KO animal. D, A
nuclear enlargement index (see Materials and Methods) was used to compare
nuclear enlargement in no flLis1 controls (CON) and Lis1 KO (KO). E, The
histogram shows the distribution of this index in CON and Lis1 KO neurons. F, The
position of the nucleus within the soma was also determined using the centroid
displacement index (see Materials and Methods). This involves determining the
centroid position of both the nucleus and soma and calculating the total
displacement distance (µm) of the nuclear centroid from the somal centroid. G,
Histogram showing the distribution of CDI found in CON and KO neurons. Bars
indicate mean +/- SD. Brainstem sections from three no flLis1 control and four Lis1
KO mice were used in the chromatolysis study. This includes analysis of 331 control
neurons and 583 Lis1 KO neurons. Significance determined by Student’s t test (D),
or Mann–Whitney test (F); *** - p < 0.001 (see Table 3.2 for details). Scale bars: 1
mm (A) and 10 µm (B, C).
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Figure 3.7: Comparing the effect of Lis1 KO in brainstem and heart. A, Sagittal brain sections of Lis1 KO mice 5
d after the initial injection of either five injections of 2 mg tamoxifen (top) or two injections of 8 mg tamoxifen
(bottom). The 2 x 8 mg treatment resulted in much higher GFP expression than the 5 x 2 mg treatment, particularly
in the brainstem and cerebellum. B, Lis1 mRNA levels normalized to B2M mRNA levels from brainstem of no Cre
control mice injected with 2 x 8 mg tamoxifen (CON), and Lis1 KO mice injected with either 5 x 2 or 2 x 8 mg
tamoxifen. Lis1 mRNA levels were significantly decreased in brainstem of 2 x 8 mg animals, but not 5 x 2 mg
animals, relative to no Cre controls, 5 d after initial injection. C, Sections of heart from 5 x 2 mg (top)- and 2 x 8 mg
(bottom)-treated Lis1 KO mice. Both the 2 x 8 and 5 x 2 mg treatments resulted in similar levels of GFP expression
in heart. D, Lis1 mRNA levels normalized to B2M mRNA levels from heart of 2 x 8 mg-injected no Cre control
(CON)-, 5 x 2 mg-, and 2 x 8 mg-treated mice. Lis1 mRNA levels were reduced significantly in both the 5 x 2 mgand 2 x 8 mg-treated mice relative to the no Cre control but were not significantly different from each other. E,
Western blotting of brainstem and heart lysates from cardiomyocyte-specific Myh6 KO mice show reduced levels of
Lis1 protein in heart, but not brainstem compared to no Cre control mice (CON). Dynein intermediate chain (DIC)
was used as a loading control. F, Whole mount brain (right) and heart (left) from Myh6 KO mouse show
recombination (GFP) in heart but not brain. Data in A, C, E, F are representative images from N = 3 mice for each
genotype. The RNA quantification in B, D represent mean of data from N = 3 animals of each treatment and
genotype +/- SD. Significance in B, D determined by one-way ANOVA; * p < 0.05, ***p < 0.001 (see Table 3.2 for
details). Scale bars: 5 mm (A, C) and 2 mm (F).
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CHAPTER 4
REGULATION OF DYNEIN BY APC AND GSK3
4.1 INTRODUCTION
Glycogen synthase kinase 3 (GSK3) is a constitutively active
serine/threonine kinase that is a downstream target of the insulin signaling
pathway. Patients with metabolic syndrome and diabetes become insensitive to
insulin, which can contribute to an increased risk of neurological disorders and
cancer (Larsson et al., 2005; Yuhara et al., 2011; Sasazuki et al., 2013; Guraya,
2015; Ramjeesingh et al., 2016). Previously published work from our lab has
established a regulatory interaction between GSK3 and dynein where GSK3
phosphorylates and inhibits the motor when cells were serum-starved (Gao et al.,
2015). When serum was added back to the cells, or insulin was added to the
medium, GSK3 was inhibited and dynein was activated leading to accumulation
at microtubule minus-ends (Gao et al., 2015).
APC interacts with GSK3 as part of the β-catenin destruction complex in
the Wnt signaling pathway. Mutations in APC that cause colorectal cancer, such
as the multiple intestinal neoplasia (MIN) mutation, disrupt this complex.
Interestingly, many anti-diabetic drugs have been tested as chemopreventive or
therapeutic treatments for colorectal cancer with mixed results (Gupta and
Dubois, 2002; Chang et al., 2012; Malek et al., 2013; Park, 2013; Yin et al., 2014;
Mendonca et al., 2015; Zhou et al., 2015; He et al., 2016; Ramjeesingh et al.,
83

2016). APC mutations have been linked to reduced efficacy of diabetes drugs as
chemotherapeutic agents, perhaps in part due to the disruption of APC’s
interaction with GSK3.
APC is also known to interact with microtubules and regulate their
dynamics, which can affect dynein function. Importantly, results from our lab
show that APC also binds directly to dynein and that the MIN mutation found in
many patients with colorectal cancer disrupts this interaction. Additionally,
presence of the MIN isoform prevents the regulatory effects of insulin signaling
on dynein (Gao et al., 2017). In this chapter, I will discuss my contributions to
these studies.

4.2 RESULTS
4.2.1 INSULIN SIGNALING PATHWAY REMAINS FUNCTIONAL IN CELLS WITH
MUTATED APC
In this study, we utilized two immortalized mouse colonic epithelial cell
lines, one expressing wild-type (WT) APC (YAMC cells) and one expressing the
truncated MIN isoform of APC (IMCE cells), to test the effects of mutated APC on
insulin signaling and dynein function (Whitehead and Joseph, 1994). To establish
if insulin signaling (and specifically GSK3 activity) would have the same effects
on dynein in IMCE cells as YAMC cells, we measured the inhibitory
phosphorylation of GSK3 on serine-9 (pS9) via western blot. As shown in Figure
4.1A/B, the ratio of pS9-GSK3 to pan-GSK3 increases significantly one hour after
treatment in both YAMC and IMCE cells, then falls back to baseline after 6 hours.
There was no significant difference in the extent of pS9-GSK3 at 1 h between the
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two cell lines (Figure 4.1C). This shows that the insulin signaling pathway has a
similar effect on GSK3 activity in cells expressing WT APC or MIN, so the effects
seen on dynein activity are either downstream of GSK3 phosphorylation, or due
to other effects (e.g., protein-protein interactions).

4.2.2 ANALYSIS OF MICROTUBULE CYTOSKELETON
Since APC is a known regulator of microtubule organization and dynein
distribution could be altered by change in the microtubule cytoskeleton, we
analyzed this factor as well. Figure 4.2 shows immunofluorescence images of
YAMC and IMCE cells stained for α-tubulin after starvation (Figure 4.2A/B) or 1h
insulin treatment (Figure 4.2C/D). All four groups had very similar microtubule
morphology at this level, so general microtubule organization does not seem to
be the major driver of the effects seen on dynein distribution.
Posttranslational modifications to tubulin can also affect motor function, so
we next examined the distribution and levels of three different modified tubulin
isoforms (tyrosinated, acetylated, and detyrosinated) via immunofluorescence
and western blot, respectively. There did not seem to be a difference in
localization or morphology of tyrosinated (Figure 4.3A-D), acetylated (E-H), or
detyrosinated (I-J) microtubules between the two cell types or after insulin
treatment. Western blot analysis of levels of these tubulin isoforms revealed no
significant difference between the two cell types for tyrosinated or acetylated
tubulin, but, surprisingly, there was significantly less detyrosinated tubulin
(GluTub) in the IMCE cells than YAMC cells (Figure 4.3K-L). Recent studies
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have shown that dynein motility is reduced on detyrosinated microtubules
(McKenney et al., 2016), so a decrease in detyrosinated tubulin levels likely
would not cause the decreased dynein activity seen in our studies.

4.2.3 DYNEIN INTERACTS WITH THE C-TERMINUS OF APC
In order to map the region of APC that interacts with dynein, we generated
constructs containing two APC fragments. As seen in the schematic in Figure
4.4A, the 746 amino acid N-terminal fragment (nAPC) is similar in size to the MIN
isoform. This region contains the oligomerization domain and armadillo repeats,
which interact with AMER proteins. The 272 amino acid C-terminal fragment
(cAPC) contains the EB1 and PDZ-binding domains, but not the basic region
known to interact with microtubules. These two fragments, along with full-length
APC (FL-APC) were cloned into an EGFP vector to express EGFP-tagged
versions of these proteins in cells. FL-APC was expressed in a small percentage
of cells and it colocalized with dynein in some cellular protrusions (Figure 4.4B).
nAPC aggregated in cytoplasmic blebs, suggesting the protein aggregates in
cells (Figure 4.4C). This fragment did not seem to localize to cellular protrusions
or colocalize with dynein as much as FL-APC. cAPC distribution was more
diffuse and dynein staining in these cells was also more diffuse, suggesting
cAPC might alter dynein distribution (Figure 4.4D). Interestingly, concurrent
expression of both nAPC and cAPC greatly reduced cell viability and decreased
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the amount of EGFP aggregation compared to nAPC-expressing cells (not
shown).
We also performed immunoprecipation (IP) of endogenous dynein to
determine if the APC fragments and dynein were interacting directly, as opposed
to simply localizing to similar subcellular regions (Figure 4.4E). nAPC was pulled
down in the dynein IP, but was also present in the mouse IgG control, so we
cannot say that this interaction is specific to dynein. However, cAPC specifically
coprecipitated with dynein and not mouse IgG. This indicates that dynein
interacts with the C-terminus of APC, which is lost in the truncating MIN mutation.

4.3 SUMMARY AND DISCUSSION
Truncating mutations of APC, specifically the MIN mutation, disrupt its
interaction with dynein and prevent the regulatory control of insulin signaling over
dynein activity. This is likely due to the interaction between dynein and APC
occurring via the C-terminus of the APC protein, which is lacking in the MIN
isoform. While disruptions in microtubule organization or posttranslational
modifications could hypothetically account for changes seen in motor activity, we
did not see any dramatic changes in the morphology of the microtubule
cytoskeleton. We did find that cells carrying the MIN allele had lower levels of
detyrosinated tubulin, but this is unlikely to cause the effects seen, as dynein is
less motile on detryosinated microtubles, so lower levels should increase dynein
motility in IMCE cells. These results have implications not only in identifying
mechanisms of carcinogenesis in APC MIN cancer models, but also in
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determining the mechanisms of decreased diabetes drug efficacy in patients
carrying the MIN allele. Additionally, this research could aid in identifying
potential neurological conditions associated with the mutation. Future studies
would identify changes in dynein function and regulation in neurons from APC
MIN mice. Specifically, we plan to learn first whether GSK3 inhibition positively
regulates motile events (i.e., increased speeds, run lengths, etc.) or if it is
important only for the initiation of transport. Next, we could determine whether
this regulation is affected in different compartments, such as the AIS or growth
cone, of cultured neurons from WT and APC MIN mice.
Additionally, we will examine whether there is crosstalk between the
signaling pathways that regulate GSK3 and Lis1/Ndel1. The Lis1 knockout
mouse described in Chapter 2 would be a good model for testing this at the
cellular and organismal level. Treating Lis1 KO mice, or DRG neurons cultured
from them, with GSK3 inhibitors to try to rescue or delay the phenotypes
observed would give insights into the regulation of axonal transport.
Finally, it will be interesting to determine the effects of the MIN mutation
on the ability of axons to regenerate. This could be done in vivo using a sciatic
nerve crush and measuring the number and distance that axons can grow past
the injury site. In conjunction, total axon length and the number of neurons
extending neurites in culture can be measured in DRG neurons from these mice
to determine regenerative capacity. The mechanism underlying any defects seen
in regeneration could be due to APC’s role as a +TIP in stabilizing microtubules,
its role as an mRNA-binding protein, or its role in the β-catenin destruction
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complex. Further analysis would be done to determine which of these
mechanisms is the cause of any results obtained.

4.4 MATERIALS AND METHODS
Cell lines
The murine young adult mouse colon (YAMC) epithelial cell line was derived
from the colonic mucosa of a transgenic mouse generated by the introduction of
a temperature-sensitive, interferon-inducible, SV40 T Ag, tsA58 (Immortomouse;
(Whitehead et al., 1993)). This line is referred to as “WT”. The Immortomouse
colon epithelial cell line (IMCE) was derived from the progeny of a cross between
the Immortomouse strain and the Apc (min/+) mouse strain (Whitehead and
Joseph, 1994). We refer to these as MIN cells. Both cell lines were first obtained
from the Center for Colon Cancer Research at the University of South Carolina
and later from a new batch from R. H. Whitehead (Vanderbilt University Medical
Center). Cell lines were validated by genotyping and PCR. Cells were maintained
at the permissive temperature (33°C) in full RPMI 1640 medium (2 mM
glutamine, 10% fetal bovine serum [FBS], 0.5 U/ml penicillin, 100 μg/ml
streptomycin, 5 U/ml murine γ-interferon, and 1% ITS [insulin, transferrin, and
selenium; Cellgro]). Cos-7 cells were maintained in full DMEM medium (2 mM
glutamine, 10% FBS, 0.5 U/ml penicillin, and 100 μg/ml streptomycin). Cell lines
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were tested frequently for mycoplasma contamination using a mycoplasma
detection kit from Thermo Fisher Scientific.
Expression constructs and transfection
EGFP-nAPC was generated by cloning a BspEI and HindIII fragment of fulllength human APC into a pEGFP C1 vector. cAPC was generated by PCR
amplification of a 747–base pair fragment of the 3′ end of full-length human APC.
An EcoR1 and BamH1 fragment was subcloned into a pET 30 EK/LIC vector
(Novagen) for expression in Escherichia coli or the pEGFP-C1 vector for
mammalian expression. The rat EGFP-IC1B construct was kindly provided by
Kevin Pfister (University of Virginia, Charlottesville, VA). The IC1B mutant was
described in Gao et al. (2015). All constructs were verified by sequencing. Cells
were transfected using Lipofectamine 2000 or 3000 (Invitrogen) according to the
manufacturer’s directions.
Antibodies
We used the following antibodies: CDK5RAP2 rabbit polyclonal antibody (pAb;
Millipore), DIC mouse monoclonal antibody (mAb; 74.1; Santa Cruz
Biotechnology), APC-M2 rabbit pAb (raised against the 15–amino acid repeat
region; described in Wang et al., 2009), DIC mouse mAb (74.1; Santa Cruz
Biotechnology), GSK-3β mouse mAb (3D10; Cell Signaling Technology),
phospho–GSK3β (Ser-9) rabbit pAb (5B3; Cell Signaling Technology), GFP
rabbit pAb (Ab290; Abcam), His-probe rabbit pAb (H-3; Santa Cruz
Biotechnology), PPARγ1 rabbit pAb (H100; Santa Cruz Biotechnology),
detyrosinated α-tubulin rabbit pAb (ab48389; Abcam), tyrosinated tubulin mouse
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mAb (TUB1A2; Sigma-Aldrich); acetylated tubulin mouse mAb (Clone 6-11-B1;
Sigma-Aldrich); and α-tubulin mAb (T5168; Sigma-Aldrich).
Measuring GSK-3β inhibition
PAGE was performed on WT and MIN cell extracts. Proteins were then
transferred to nitrocellulose membrane. Membranes were blocked using Li-Cor
Odyssey TBS Blocking Buffer and then probed with a mouse mAb to pan-GSK3β and rabbit mAb to phospho–GSK-3β (serine 9), both at 1:1000. LiCor IRDye
680LT donkey anti-rabbit and 800CW donkey anti-mouse secondary antibodies
were diluted in the Odyssey blocking buffer at 1:10,000. The membrane was then
imaged using the Li-Cor Odyssey Sa system, and band intensities were
measured using ImageStudio software.
Protein interaction studies in cells Cos-7 cells were used because of the
difficulty in transfecting the WT and MIN colon cell lines. Cells were transfected
with EGFP, EGFP-nAPC, EGFP-cAPC, or EGFP-IC1B constructs. After 16 h,
cells were starved for 4 h, lysed in the lysis buffer on ice for 30 min, and then
centrifuged at 50,000 × g for 30 min. Cell lysates were incubated overnight with
agarose beads conjugated to DIC antibody or normal mouse IgG (Santa Cruz
Biotechnology). Beads were washed extensively in 50 mM Tris, pH 7.5, 0.5%
NP-40, 0.1% Triton X-100, 125 mM NaCl, 1 mM MgCl2, and 5 mM EDTA and
then in PBST, and then processed for SDS–PAGE and Western blotting. Lysates
were prepared 24–36 h after transfection and no starvation step was included.
Lysates were sonicated for 10 pulses at level 1 with 10% output three times,
incubated on ice for 10 min, and then centrifuged at 17,000 × g for 20 min at 4°C.
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Cell lysates were incubated overnight with agarose beads conjugated to DIC
antibody or protein A beads alone. After transfection, cells were starved for 12 h
and then exposed to 3 μM CT99021 for 12 h in full medium (containing both ITS
and FBS).
Statistics
All analyses were carried out using GraphPad Prism, version 5.00 for Mac OSX.
In most of the figures, error bars represent ±95% confidence interval (CI). Oneway analysis of variance (ANOVA) with Tukey’s multiple comparison tests or
paired or unpaired, two-tailed Student’s t test were used as indicated in the figure
legends. Immunofluorescence measurements were made using ImageJ Fiji. For
graphs from Western blots, at least three repeats of the experiments were
performed.
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Figure 4.1: Extent of GSK3 inhibition remains the same in WT and MIN cells. A,
Representative Western blot of extracts from YAMC and IMCE cells treated with
insulin for 0, 1, or 6 hours. pS9 (red); pan-GSK3 (green) B, Li-Cor densitometry
analysis of three Western blots shows mean ± 95% CI. *p < 0.05 by one-way
ANOVA. C, Average increase in S9/pan-GSK3 after 1 h was determined from five
Western blots. Figure adapted from Gao et al., 2017.
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FIGURE 4.2: Microtubule organization is similar in WT and MIN cells with and
without 1-h insulin exposure. Normal full culture medium was replaced with
serum- and insulin-free medium for 12 h, and then insulin (ITS, 10 µM) was added
for 1 h to one set of cultures. A, WT cells and B, MIN cells with no added insulin or
C, WT cells and D, MIN cells that were exposed to insulin for 1 h were fixed and
processed for α-tubulin IF. Insets, individual cells at higher magnification (63X).
Scale bars, 50 µm (20X image), 10 µm (inset). Figure adapted from Gao et al.,
2017.
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Figure 4.3: Comparison of tubulin modifications in WT vs. MIN cells. A, Western blot of
extracts from WT and MIN cells probed for DIC, tyrosinated tubulin (Tyr Tub), acetylated
tubulin (Ac Tub) and detyrosinated tubulin (Glu Tub). B, Band intensity was measured for 3
separate experiments. The graph shows the ratio of MIN to WT levels for each antibody in A.
The data are shown as the average +/- 95% CI, and statistical differences determine by
ANOVA of three separate experiments. *=p<0.05, ***=p<0.001. C-F. WT (left) and MIN cells
(right) stained for tyrosinated tubulin at 0 and 1 hour after insulin. G-J. WT (left) and MIN
cells (right) stained for acetylated tubulin at 0 and 1 hour after insulin. K-L. WT (left) and MIN
cells (right) stained costained for acetylated and detyrosinated tubulin. Scale bar for C-J =
25µm. Scale bar for K and L = 2.5µm. Figure adapted from Gao et al., 2017.
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FIGURE 4.4: A C-terminal APC fragment expressed in Cos-7 cells
coimmunoprecipitates with endogenous dynein. A, Location of an N-terminal
746–amino acid APC fragment (nAPC) and a C-terminal 272–amino acid APC
(cAPC) fragment used in several experiments. Also shown is the 850–amino acid
MIN isoform. B, Western blot of proteins in a dynein immunoprecipitate. Top,
endogenous dynein (end. DIC) is precipitated by a dynein antibody but not by
nonspecific mouse IgG. Middle, EGFPnAPC is present in both the IgG and the DIC
immunoprecipitate. Bottom, EGFP-cAPC coprecipitated specifically with dynein, not
IgG. The lower anti-GFP–labeled band may be a proteolytic fragment or a modified
peptide that is enriched in the DIC immunoprecipitate. C, Full-length APC fused to
EGFP (green) transiently expressed in Cos-7 cells localizes along MTs in cellular
protrusions. DIC (red) is concentrated in the cytoplasm but present near the
peripheral regions of protrusions (arrows). D, EGFP-nAPC (green) is enriched in
large aggregates in the cytoplasm. Very small puncta of EGFP-nAPC associate with
DIC (red) in cellular protrusions at the cell periphery (arrow). E, EGFP-cAPC (green)
is diffuse throughout the cytoplasm and is present in the nucleus. Scale bar, 10 µm.
Figure adapted from (Gao et al., 2017).
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CHAPTER 5
DISCUSSION AND CONCLUSIONS
Cytoplasmic dynein is a critical mediator of a diverse array of cellular
functions, such as nuclear migration, multiple events during mitosis, and
microtubule-based intracellular transport. These processes all must be tightly
regulated to avoid potential disease states, such as neurodegeneration and
cancer. This is can be done via protein-protein interactions with Lis1/Ndel1,
dynactin, and APC amongst others, and posttranslational modifications of the
motor itself or its regulators. Disrupting these regulatory entities can impair axon
regeneration after injury, cause neurological diseases, and possibly play a role in
cancer and diabetes. Specifically, haploinsufficiency of Lis1 during development
causes lissencephaly in humans while postdevelopmental knockout of Lis1 in
mice can cause pathology consistent with neurodegeneration, and mutations in
APC can cause colorectal cancer. In the studies described in this dissertation, we
further investigated the potential consequences of these disruptions on dyneindependent transport.
The function of Lis1 during neurodevelopment has been well
characterized due to mutations in this gene causing lissencephaly in humans.
Since Lis1 is still highly expressed in the adult mouse nervous system, we
wanted to investigate its role postdevelopmentally, focusing particularly on
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axonal transport. To do this, we used an inducible knockout system to circumvent
the effects of Lis1 depletion on developmental process like neuronal migration,
spindle orientation and nuclear envelope breakdown (at least in post-mitotic cells,
such as neurons), and interkinetic nuclear migration. This revealed an important
postdevelopmental role for Lis1 in mice. Specifically, we saw a rapid decline in
health, sensorimotor defects, and death. At the same time, we saw disruption of
axonal transport, which was likely the cause of pathological changes in cultured
DRG neurons (axonal swellings and altered neurofilament distribution) and in
cardiorespiratory neurons in brainstem sections (chromatolysis). This suggests
that Lis1 plays a critical role in neuronal maintenance, at least in part through
axonal transport, postdevelopmentally. There were also defects in axon growth in
cultured adult DRG neurons, which indicates Lis1 may play a role in axon
regeneration.
In more broad terms, these experiments show that disruption of axonal
transport (and potentially other Lis1-related cellular processes) can lead to a
degenerative phenotype that primarily affects brainstem neurons and
sensorimotor systems in mice. This is interesting because several
neurodegenerative diseases are associated with defects in axonal transport, but
it is not known whether this is a byproduct of other dysfunctional processes or
one of the causes of degeneration itself. Our studies show that it is quite possible
that impaired axonal transport is sufficient to cause axonal pathology and a
similar behavioral phenotype to other neurodegenerative disease models, such
as ALS.
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The differences seen between Lis1 deficient mouse models and human
patients with lissencephaly were a little surprising at first, but may make sense in
the context of long-distance axonal transport. That is, human neurons must
extend their axonal processes over a much further distance than even the
longest mouse axons. If Lis1 is responsible for regulating long-distance transport,
then it makes sense that a 50% reduction in Lis1 protein levels would have a
more noticeable effect on longer human axons than the shorter mouse axons. If
we also consider the possibility that any defects in transport can lead to
accumulation of effects over time and distance, then it is easy to see how
reduced Lis1 levels in humans produce a much more severe phenotype than
seen in mice.
A similar principle may also partially why different parts of the nervous
system are affected in the two models (cortex in humans, brainstem/motor
neurons in our mouse model). First, in humans, Lis1 haploinsufficiency causes
mitotic and migrational defects, which would preferentially affect cortical neurons
because they require more cell divisions to become neurons than those in the
brainstem. Additionally, these cortical neurons have to migrate much further in
humans than mice, which may make this process more sensitive to reduced Lis1
levels. This may be why Lis1 heterozygous mice, where Lis1 levels are reduced
during development, don’t exhibit the drastic cortical defects observed in
humans.
In our inducible Lis1 knockout mice, these neurodevelopmental processes
are bypassed, allowing us to investigate the effects loss of Lis1 may have in
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addition to mitotic and migrational defects seen in lissencephaly patients. The
fact that we observe minimal recombination and Lis1 loss in the cortex indicates
that the phenotype observed is not due to cortical dysfunction. In fact, we see
reduced Lis1 mRNA and protein levels, as well as signs of axonal pathology, in
the brainstem of our Lis1 knockout mice. Sensorimotor defects are also seen in
the hindlimbs of these mice. The susceptibility of these neurons to reduced Lis1
expression may be due to their relatively long axon length.
These results raise many questions that are potential avenues for future
research. First, since the phenotype developed in the Lis1 knockout mice has
many parallels with neurodegenerative diseases linked to defective axonal
transport, such as ALS, Charcot-Marie-Tooth, and SMA-LED (Harms et al., 2012;
Ikenaka et al., 2012; Sabblah et al., 2018), it is possible that mild perturbation of
this interaction could produce a less severe phenotype than that caused by
haploinsufficiency in humans. One way the interaction could be altered is if Lis1
mutations exist that produce a milder effect than those that cause lissencephaly.
Hypothetically, these mutations would have minimal impact on dynein-dependent
developmental processes while potentially impairing transport-related processes
postdevelopmentally. Our lab is currently researching published sequencing
data, as well as working with the Greenwood Genetics Center, to determine if
there are any such mutations known in the Lis1 gene that can be linked to other
neurological diseases.
It would also be interesting to determine what role Lis1 plays in axon
regeneration. As described in Chapter 4, there are injury-induced signals that are
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retrogradely transported by dynein, which bolster regenerative capacity (Hanz
and Fainzilber, 2006; Ben-Yaakov et al., 2012). These signals may also require
Lis1 for efficient transport to promote the switch from arborizing axon growth to
elongating axon growth. Additionally, Lis1 and dynein are required to advance
microtubules in the growth cone during fast axonal outgrowth and downregulation
of Lis1 during development limits axonal outgrowth (Grabham et al., 2007;
Kumamoto et al., 2017). Given the axon growth defects seen in DRG cultures
from Lis1 KO mice, it will be interesting to determine the mechanism through
which this is occurring. This is something we have already begun investigating by
looking at the effect of Lis1 depletion on retrograde injury signaling via
accumulation of the transcription factor, phospho-STAT3, in the nucleus of DRG
neurons following sciatic nerve injury.
To better understand the role of APC in dynein-dependent transport, we
took advantage of a well-characterized cancer-causing mutation in the APC
gene, the MIN mutation, to explore how disruption of APC function leads to
aberrant dynein regulation. Our results show that the MIN mutation disrupts the
normal dynein-APC interaction at microtubule plus ends. This also abrogates the
regulatory effects of insulin signaling on dynein-dependent transport. In cells
expressing only full-length APC, insulin signaling decreased GSK3-dependent
phosphorylation of dynein, thus increasing minus-end dependent transport,
shown by increased accumulation of dynein at the centrosome. However, in cells
with the MIN mutation (IMCE cells), this regulatory effect was diminished and
accumulation of dynein at the centrosome was not seen, despite similar levels of
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insulin-dependent GSK3 inhibition. This could be an effect of decreased efficacy
of insulin-sensitizing drugs as chemopreventive or therapeutic agents in patients
with colorectal cancer. Further investigation is required to determine the precise
implications of this dysregulation, but some potential effects include disruption of
transport-dependent degradative processes, such as mitophagy and the endolysosomal pathway, and altered mitochondrial distribution. If this effect extends to
other dynein-dependent processes, then this could influence mitotic events such
as nuclear envelope breakdown, microtubule capture at kinetochores, or spindle
formation and orientation in APC MIN cells. Alterations in these processes could
provide mechanistic insights into the initiation of MIN-induced colorectal cancer.
One other project would determine the mechanistic role of APC in axon
regeneration. Since APC serves many functions in neurons, including
microtubule stabilization, RNA-binding, β-catenin destruction, and dynein
regulation, it seems likely that the truncating mutation seen in patients with
colorectal cancer could influence axon growth after injury. If defects in
regeneration are seen, then we would investigate which of APC’s functions are
the cause of this phenotype. There is evidence that APC plays a role in axon
growth and arborization during development, as well as axon sorting in the PNS
(Chen et al., 2011; Elbaz et al., 2016).
While the studies conducted in this dissertation focus on two dynein
regulatory pathways, there are a number of other proteins and signaling
cascades that impact microtubule-based transport (e.g., dynactin, Ndel1, BicD2,
etc). It is currently unclear how all of these elements coordinate to regulate
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axonal transport. Having a comprehensive view of how axonal transport is
regulated will help us understand how and why transport is perturbed in many
degenerative diseases and how this contributes to the progression of the
disease. This is an area of ongoing research, as it may be possible to manipulate
different regulatory components to alleviate the effects of defective transport
seen in many neurological diseases, such as Alzheimer’s, schizophrenia, and
ALS.
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